Back to Journals » OncoTargets and Therapy

OncoTargets and Therapy


Journal Articles:

- 2,671 records -

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K

OncoTargets and Therapy 2018, 11:2287-2293

Published Date: 20 April 2018

Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients

Chen Q, Li R, Zhang Z, Deng Q, Li K, Wang H, Yang X, Wu Y

OncoTargets and Therapy 2018, 11:2279-2286

Published Date: 20 April 2018

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Xu J, Guo X, Jing M, Sun T

OncoTargets and Therapy 2018, 11:2269-2275

Published Date: 19 April 2018

Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer

Ni C, Yang P, Guo J, Ye M

OncoTargets and Therapy 2018, 11:2259-2267

Published Date: 19 April 2018

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N

OncoTargets and Therapy 2018, 11:2241-2250

Published Date: 19 April 2018

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X

OncoTargets and Therapy 2018, 11:2227-2239

Published Date: 19 April 2018

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients

Lu HY, Qin J, Han N, Lei L, Xie F, Li C

OncoTargets and Therapy 2018, 11:2217-2226

Published Date: 20 April 2018

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5

Wei X, Yu L, Kong X

OncoTargets and Therapy 2018, 11:2205-2216

Published Date: 18 April 2018

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Du L, Chen T, Zhao K, Yang D

OncoTargets and Therapy 2018, 11:2195-2202

Published Date: 17 April 2018

The role of Hippo signal pathway in breast cancer metastasis

Wei C, Wang Y, Li X

OncoTargets and Therapy 2018, 11:2185-2193

Published Date: 17 April 2018

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females

Huang Y, Jian W, Zhao J, Wang G

OncoTargets and Therapy 2018, 11:2177-2184

Published Date: 17 April 2018

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma MZ, Yuan SQ, Chen Y, Zhou ZW

OncoTargets and Therapy 2018, 11:2169-2176

Published Date: 13 April 2018

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis

Zhou Y, Cheng S, Chen S, Zhao Y

OncoTargets and Therapy 2018, 11:2157-2167

Published Date: 13 April 2018

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

Wang HY, Yu X, Fan Y, Jiang Y

OncoTargets and Therapy 2018, 11:2149-2155

Published Date: 13 April 2018

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients

Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK

OncoTargets and Therapy 2018, 11:2131-2139

Published Date: 12 April 2018

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma

Huang CK, Huang ZC, Zhao XK, Wang YH, Zhao HQ, Zhong ZH, Wang L

OncoTargets and Therapy 2018, 11:2111-2120

Published Date: 12 April 2018

Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells

An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G

OncoTargets and Therapy 2018, 11:2097-2109

Published Date: 13 April 2018

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Published Date: 11 April 2018

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Published Date: 11 April 2018

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis

Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ

OncoTargets and Therapy 2018, 11:2075-2082

Published Date: 11 April 2018

Role of the NFκB-signaling pathway in cancer

Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ

OncoTargets and Therapy 2018, 11:2063-2073

Published Date: 11 April 2018

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer

Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T

OncoTargets and Therapy 2018, 11:2051-2061

Published Date: 11 April 2018

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion

Liu S, Ding G, Zhou Z, Feng C

OncoTargets and Therapy 2018, 11:2029-2036

Published Date: 9 April 2018

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity

Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G

OncoTargets and Therapy 2018, 11:2017-2028

Published Date: 9 April 2018

Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination

Zhou Y, Wang K, Zhou N, Huang T, Zhu J, Li J

OncoTargets and Therapy 2018, 11:2007-2015

Published Date: 6 April 2018

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

Peng C, Gu L, Wang L, Huang Q, Wang B, Guo G, Fan Y, Gao Y, Ma X, Zhang X

OncoTargets and Therapy 2018, 11:1997-2005

Published Date: 6 April 2018

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy

Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2018, 11:1973-1980

Published Date: 5 April 2018

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway

Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W

OncoTargets and Therapy 2018, 11:1941-1948

Published Date: 5 April 2018

Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS

OncoTargets and Therapy 2018, 11:1929-1939

Published Date: 5 April 2018

Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary

Aktas G, Kus T, Metin T, Kervancioglu S, Elboga U

OncoTargets and Therapy 2018, 11:1885-1889

Published Date: 4 April 2018

Antiangiogenic effects of AA-PMe on HUVECs in vitro and zebrafish in vivo

Jing Y, Wang G, Xiao Q, Zhou Y, Wei Y, Gong Z

OncoTargets and Therapy 2018, 11:1871-1884

Published Date: 4 April 2018

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Zhou L, Du Y, Kong L, Zhang X, Chen Q

OncoTargets and Therapy 2018, 11:1861-1869

Published Date: 4 April 2018

D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B

OncoTargets and Therapy 2018, 11:1833-1847

Published Date: 4 April 2018

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C

OncoTargets and Therapy 2018, 11:1821-1831

Published Date: 3 April 2018

Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review

Liu Q, Duan JH, Zheng YM, Luo J, Cai XP, Tan HY

OncoTargets and Therapy 2018, 11:1813-1819

Published Date: 3 April 2018

Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis

Yuan H, Wu Y, Zhang J, Shi G, Liu D, He Y, Lu Z, Wu P, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:1801-1811

Published Date: 3 April 2018

Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis

Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B

OncoTargets and Therapy 2018, 11:1787-1799

Published Date: 29 March 2018

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells

Chiu CM, Huang SY, Chang SF, Liao KF, Chiu SC

OncoTargets and Therapy 2018, 11:1777-1785

Published Date: 29 March 2018

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells

Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D

OncoTargets and Therapy 2018, 11:1767-1776

Published Date: 3 April 2018

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

Meng X, Fu R

OncoTargets and Therapy 2018, 11:1757-1765

Published Date: 29 March 2018

Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C

OncoTargets and Therapy 2018, 11:1743-1756

Published Date: 28 March 2018

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L

OncoTargets and Therapy 2018, 11:1733-1741

Published Date: 27 March 2018

miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer

Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR

OncoTargets and Therapy 2018, 11:1721-1732

Published Date: 26 March 2018

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L

OncoTargets and Therapy 2018, 11:1707-1720

Published Date: 28 March 2018

Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma

Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G

OncoTargets and Therapy 2018, 11:1697-1706

Published Date: 26 March 2018

Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer

Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L

OncoTargets and Therapy 2018, 11:1683-1695

Published Date: 23 March 2018

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

Yao YF, Li QR, Wang H

OncoTargets and Therapy 2018, 11:1671-1681

Published Date: 23 March 2018

The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women

Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J

OncoTargets and Therapy 2018, 11:1665-1670

Published Date: 23 March 2018

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy

Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL

OncoTargets and Therapy 2018, 11:1655-1664

Published Date: 23 March 2018

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect

Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C

OncoTargets and Therapy 2018, 11:1643-1653

Published Date: 23 March 2018

Effects of isoliquiritigenin on ovarian cancer cells

Li N, Yang L, Deng XN, Sun YN

OncoTargets and Therapy 2018, 11:1633-1642

Published Date: 22 March 2018

Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies

Ma P, Dai S, Jin C, Yao Y, Zou C

OncoTargets and Therapy 2018, 11:1617-1623

Published Date: 21 March 2018

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y

OncoTargets and Therapy 2018, 11:1595-1599

Published Date: 20 March 2018

High expression of COL10A1 is associated with poor prognosis in colorectal cancer

Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H

OncoTargets and Therapy 2018, 11:1571-1581

Published Date: 20 March 2018

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

Zhou W, Wang L, Miao Y, Xing R

OncoTargets and Therapy 2018, 11:1543-1552

Published Date: 19 March 2018

Functional miRNAs in breast cancer drug resistance

Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH

OncoTargets and Therapy 2018, 11:1529-1541

Published Date: 19 March 2018

Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature

Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y

OncoTargets and Therapy 2018, 11:1521-1528

Published Date: 16 March 2018

STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma

Zhao Q, Zhu YJ, Liu L, Wang H, Jiang S, Hu X, Guo J

OncoTargets and Therapy 2018, 11:1511-1519

Published Date: 16 March 2018

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

OncoTargets and Therapy 2018, 11:1501-1509

Published Date: 16 March 2018

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis

Yu G, Zhang W, Zhu L, Xia L

OncoTargets and Therapy 2018, 11:1491-1499

Published Date: 16 March 2018

Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells

Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM

OncoTargets and Therapy 2018, 11:1475-1490

Published Date: 15 March 2018

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y

OncoTargets and Therapy 2018, 11:1457-1474

Published Date: 15 March 2018

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T

OncoTargets and Therapy 2018, 11:1433-1445

Published Date: 15 March 2018

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X

OncoTargets and Therapy 2018, 11:1423-1432

Published Date: 15 March 2018

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

OncoTargets and Therapy 2018, 11:1413-1422

Published Date: 14 March 2018

Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer

Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X

OncoTargets and Therapy 2018, 11:1403-1412

Published Date: 14 March 2018

Fast hemostasis: a win-win strategy for ultrasound and microwave ablation

Guo J, Tian G, Zhao Q, Jiang T

OncoTargets and Therapy 2018, 11:1395-1402

Published Date: 13 March 2018

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer

Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J

OncoTargets and Therapy 2018, 11:1363-1372

Published Date: 13 March 2018

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H

OncoTargets and Therapy 2018, 11:1353-1362

Published Date: 12 March 2018

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

Zeng B, Zhou M, Wu H, Xiong Z

OncoTargets and Therapy 2018, 11:1333-1343

Published Date: 12 March 2018

CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis

Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN

OncoTargets and Therapy 2018, 11:1323-1331

Published Date: 8 March 2018

Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China

Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, Ren T

OncoTargets and Therapy 2018, 11:1315-1322

Published Date: 7 March 2018

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma

Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB

OncoTargets and Therapy 2018, 11:1305-1314

Published Date: 7 March 2018

The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis

Liang CJ, Xu YC, Ge H, Li GM, Wu JX

OncoTargets and Therapy 2018, 11:1293-1303

Published Date: 7 March 2018

Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer

Bai WK, Zhang W, Hu B

OncoTargets and Therapy 2018, 11:1267-1274

Published Date: 6 March 2018

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection

Li D, Zhou Y, Liu Y, Lin Y, Yu M, Lu X, Huang B, Sun Z, Jian Z, Hou B

OncoTargets and Therapy 2018, 11:1259-1265

Published Date: 6 March 2018

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Published Date: 5 March 2018

Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer

Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

OncoTargets and Therapy 2018, 11:1215-1222

Published Date: 5 March 2018

Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma

Liang CJ, Xu Y, Ge H, Li G, Wu J

OncoTargets and Therapy 2018, 11:1203-1214

Published Date: 5 March 2018

Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis

Guo G, Fu M, Wei S, Chen R

OncoTargets and Therapy 2018, 11:1193-1201

Published Date: 2 March 2018

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F

OncoTargets and Therapy 2018, 11:1183-1192

Published Date: 2 March 2018

Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression

Wang X, Peng J, Wang J, Li M, Wu D, Wu S, Liao J, Dou J

OncoTargets and Therapy 2018, 11:1173-1182

Published Date: 2 March 2018

Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study

Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN

OncoTargets and Therapy 2018, 11:1141-1148

Published Date: 1 March 2018

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H

OncoTargets and Therapy 2018, 11:1121-1139

Published Date: 1 March 2018

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA

OncoTargets and Therapy 2018, 11:1117-1120

Published Date: 1 March 2018

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P

OncoTargets and Therapy 2018, 11:1105-1115

Published Date: 1 March 2018

TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo

Hu Z, Hou D, Wang X, You Z, Cao X

OncoTargets and Therapy 2018, 11:1095-1103

Published Date: 1 March 2018

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J

OncoTargets and Therapy 2018, 11:1077-1086

Published Date: 28 February 2018

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis

Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL

OncoTargets and Therapy 2018, 11:1067-1075

Published Date: 27 February 2018

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y

OncoTargets and Therapy 2018, 11:1055-1066

Published Date: 1 March 2018

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Zhang Y, Xu L, Peng M

OncoTargets and Therapy 2018, 11:1045-1054

Published Date: 27 February 2018

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer

Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y

OncoTargets and Therapy 2018, 11:1037-1044

Published Date: 27 February 2018

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J

OncoTargets and Therapy 2018, 11:1025-1035

Published Date: 26 February 2018

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis

Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X

OncoTargets and Therapy 2018, 11:997-1004

Published Date: 26 February 2018

Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway

Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W

OncoTargets and Therapy 2018, 11:983-996

Published Date: 26 February 2018

Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy

Cai L, Li Y, Yang X, Lian X, Guo M, Xiao S, Wang W, Zhang H

OncoTargets and Therapy 2018, 11:967-973

Published Date: 23 February 2018

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W

OncoTargets and Therapy 2018, 11:943-953

Published Date: 22 February 2018

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G

OncoTargets and Therapy 2018, 11:933-941

Published Date: 22 February 2018

The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J

OncoTargets and Therapy 2018, 11:919-932

Published Date: 21 February 2018

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma

Sheng XR, Xing SG, Wang RD, Chen K, Jia WD

OncoTargets and Therapy 2018, 11:909-917

Published Date: 21 February 2018

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker

Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong Y, Zhang H, Chen C, Su Z, Guo R

OncoTargets and Therapy 2018, 11:891-901

Published Date: 20 February 2018

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH

OncoTargets and Therapy 2018, 11:883-890

Published Date: 19 February 2018

Klotho ameliorates sepsis-induced acute kidney injury but is irrelevant to autophagy

Chen X, Tong H, Chen Y, Chen C, Ye J, Mo Q, Zhao G, Hong G, Zheng C, Lu Z

OncoTargets and Therapy 2018, 11:867-881

Published Date: 19 February 2018

Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:851-865

Published Date: 16 February 2018

Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells

Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y

OncoTargets and Therapy 2018, 11:843-849

Published Date: 16 February 2018

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R

OncoTargets and Therapy 2018, 11:833-842

Published Date: 16 February 2018

MiR-1180-5p regulates apoptosis of Wilms’ tumor by targeting p73

Jiang X, Li H

OncoTargets and Therapy 2018, 11:823-831

Published Date: 16 February 2018

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J

OncoTargets and Therapy 2018, 11:801-808

Published Date: 15 February 2018

The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis

Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X

OncoTargets and Therapy 2018, 11:791-800

Published Date: 14 February 2018

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis

Li L, Sun F, Chen X, Zhang M

OncoTargets and Therapy 2018, 11:781-789

Published Date: 14 February 2018

Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells

Shi D, Zhu Y, Niu P, Zhou J, Chen H

OncoTargets and Therapy 2018, 11:757-767

Published Date: 9 February 2018

Molecular features of giant-cell carcinoma of the lung: a case report and literature review

Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J

OncoTargets and Therapy 2018, 11:751-756

Published Date: 9 February 2018

Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study

Yang W, Gu L, Yang C, Liu T

OncoTargets and Therapy 2018, 11:743-749

Published Date: 8 February 2018

Prognostic significance of epidermal growth factor receptor expression in glioma patients

Li JH, Liang RF, Song C, Xiang YF, Liu YH

OncoTargets and Therapy 2018, 11:731-742

Published Date: 7 February 2018

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P

OncoTargets and Therapy 2018, 11:721-730

Published Date: 5 February 2018

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L

OncoTargets and Therapy 2018, 11:711-720

Published Date: 5 February 2018

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]

Guo L, Huang S, Wang X

OncoTargets and Therapy 2018, 11:687-688

Published Date: 2 February 2018

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer

Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L

OncoTargets and Therapy 2018, 11:677-685

Published Date: 1 February 2018

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ

OncoTargets and Therapy 2018, 11:665-675

Published Date: 1 February 2018

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance

Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C

OncoTargets and Therapy 2018, 11:651-663

Published Date: 1 February 2018

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1

Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R

OncoTargets and Therapy 2018, 11:639-649

Published Date: 31 January 2018

The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL

OncoTargets and Therapy 2018, 11:619-627

Published Date: 31 January 2018

Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y

OncoTargets and Therapy 2018, 11:609-618

Published Date: 31 January 2018

ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3

Wang Y, Shao F, Chen L

OncoTargets and Therapy 2018, 11:599-608

Published Date: 31 January 2018

Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients

Zhao S, Zhang L, Gu Z, Zhu C, Fang S, Yang N, Wang F, Guan L, Luo L, Gao C

OncoTargets and Therapy 2018, 11:555-561

Published Date: 24 January 2018

Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy

Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G

OncoTargets and Therapy 2018, 11:547-554

Published Date: 24 January 2018

Nomogram for predicting survival in patients with pancreatic cancer

Song W, Miao DL, Chen L

OncoTargets and Therapy 2018, 11:539-545

Published Date: 24 January 2018

The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX

OncoTargets and Therapy 2018, 11:509-519

Published Date: 23 January 2018

Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis

Mu S, Ai L, Fan F, Sun C, Hu Y

OncoTargets and Therapy 2018, 11:499-507

Published Date: 23 January 2018

ROS-dependent Bax/Bcl2 and caspase 3 pathway-mediated apoptosis induced by zineb in human keratinocyte cells

Ali D, Tripathi A, Al Ali H, Shahi Y, Mishra KK, Alarifi S, Alkahtane AA, Manohardas S

OncoTargets and Therapy 2018, 11:489-497

Published Date: 23 January 2018

Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy

Saito S, Ozawa H, Ikari Y, Nakahara N, Ito F, Sekimizu M, Fukada J, Kameyama K, Ogawa K

OncoTargets and Therapy 2018, 11:483-488

Published Date: 23 January 2018

Apatinib-treated advanced medullary thyroid carcinoma: a case report

Chen K, Gao Y, Shi F, Cao G, Bao J

OncoTargets and Therapy 2018, 11:459-463

Published Date: 19 January 2018

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z

OncoTargets and Therapy 2018, 11:449-457

Published Date: 19 January 2018

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma

Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y

OncoTargets and Therapy 2018, 11:441-448

Published Date: 19 January 2018

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB

OncoTargets and Therapy 2018, 11:419-426

Published Date: 18 January 2018

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH

OncoTargets and Therapy 2018, 11:409-418

Published Date: 17 January 2018

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway

Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N

OncoTargets and Therapy 2018, 11:395-408

Published Date: 18 January 2018

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y

OncoTargets and Therapy 2018, 11:383-393

Published Date: 17 January 2018

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z

OncoTargets and Therapy 2018, 11:375-381

Published Date: 17 January 2018

Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate

Zhang L, Hou S, Li B, Pan J, Jiang L, Zhou G, Gu H, Zhao C, Lu H, Ma F

OncoTargets and Therapy 2018, 11:361-373

Published Date: 15 January 2018

Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis

Ge H, Yan Y, Guo L, Tian F, Wu D

OncoTargets and Therapy 2018, 11:351-359

Published Date: 15 January 2018

Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies

Schicho A, Pereira PL, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P

OncoTargets and Therapy 2018, 11:345-350

Published Date: 12 January 2018

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing

Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T

OncoTargets and Therapy 2018, 11:337-344

Published Date: 12 January 2018

High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas

Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS

OncoTargets and Therapy 2018, 11:323-335

Published Date: 11 January 2018

A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma

Zheng Z, Wang Q, Zhang W, Zhang X, Huang D

OncoTargets and Therapy 2018, 11:307-311

Published Date: 11 January 2018

Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer

Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ

OncoTargets and Therapy 2018, 11:301-306

Published Date: 11 January 2018

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T

OncoTargets and Therapy 2018, 11:291-299

Published Date: 9 January 2018

A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrence

He Y, Ma J, Wang A, Wang W, Luo S, Liu Y, Ye X

OncoTargets and Therapy 2018, 11:253-269

Published Date: 5 January 2018

miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells

Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS

OncoTargets and Therapy 2018, 11:239-252

Published Date: 4 January 2018

Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance

Vert A, Castro J, Ribó M, Vilanova M, Benito A

OncoTargets and Therapy 2018, 11:221-237

Published Date: 4 January 2018

RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

Liu B, Wang C, Chen P, Cheng B, Cheng Y

OncoTargets and Therapy 2018, 11:211-220

Published Date: 4 January 2018

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X

OncoTargets and Therapy 2018, 11:201-209

Published Date: 8 January 2018

Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling

Hu P, Cheng B, He Y, Wei Z, Wu D, Meng Z

OncoTargets and Therapy 2018, 11:193-200

Published Date: 4 January 2018

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A

OncoTargets and Therapy 2018, 11:185-191

Published Date: 3 January 2018

Cancer stem cells, the ultimate targets in cancer therapy

Shabbir A, Esfandyari T, Farassati F

OncoTargets and Therapy 2018, 11:183-184

Published Date: 3 January 2018

A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T

OncoTargets and Therapy 2018, 11:157-161

Published Date: 28 December 2017

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy

Castelli G, Pelosi E, Testa U

OncoTargets and Therapy 2018, 11:131-155

Published Date: 28 December 2017

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL

OncoTargets and Therapy 2018, 11:123-129

Published Date: 28 December 2017

The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1

Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S

OncoTargets and Therapy 2018, 11:103-112

Published Date: 27 December 2017

The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans

Liu X, Zheng D, Lu G, Yang B

OncoTargets and Therapy 2018, 11:97-102

Published Date: 22 December 2017

Prognosis of patients with primary malignant main stem bronchial tumors: 7,418 cases based on the SEER database

Ma K, Sun F, Yang X, Wang S, Wang L, Jin Y, Shi Y, Jiang W, Zhan C, Wang Q

OncoTargets and Therapy 2018, 11:83-95

Published Date: 22 December 2017

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer

Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O

OncoTargets and Therapy 2018, 11:37-46

Published Date: 21 December 2017

Four-miRNA signature as a prognostic tool for lung adenocarcinoma

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J

OncoTargets and Therapy 2018, 11:29-36

Published Date: 21 December 2017

Identification of epigenetically altered genes and potential gene targets in melanoma using bioinformatic methods

Duan HH, Jiang K, Wei DK, Zhang LJ, Cheng DL, Lv M, Xu YB, He AM

OncoTargets and Therapy 2018, 11:9-15

Published Date: 20 December 2017

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman [Retraction]

Gao K, Li H, Huang C, Li H, Fang J, Tian C

OncoTargets and Therapy 2017, 10:5945-5946

Published Date: 18 December 2017

SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma [Retraction]

Huang W, Huang H, Wang L, Hu J, Song W

OncoTargets and Therapy 2017, 10:5935-5936

Published Date: 18 December 2017

Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray

Wang M, Ruan S, Ming J, Dong F

OncoTargets and Therapy 2017, 10:5927-5934

Published Date: 13 December 2017

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules

He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR

OncoTargets and Therapy 2017, 10:5915-5926

Published Date: 13 December 2017

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL

OncoTargets and Therapy 2017, 10:5907-5914

Published Date: 12 December 2017

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS

OncoTargets and Therapy 2017, 10:5899-5906

Published Date: 12 December 2017

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer

Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X

OncoTargets and Therapy 2017, 10:5883-5897

Published Date: 12 December 2017

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D

OncoTargets and Therapy 2017, 10:5863-5872

Published Date: 11 December 2017

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M

OncoTargets and Therapy 2017, 10:5855-5862

Published Date: 11 December 2017

Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma

Huang JF, Zou QZ, Qian DQ, Zhou LY, Yang B, Chu JJ, Pang QF, Wang KW, Zhang FZ

OncoTargets and Therapy 2017, 10:5835-5841

Published Date: 8 December 2017

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer

Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z

OncoTargets and Therapy 2017, 10:5827-5834

Published Date: 8 December 2017

Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway

Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L

OncoTargets and Therapy 2017, 10:5817-5826

Published Date: 8 December 2017

Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies

Zhu J, Miao C, Liu S, Tian Y, Zhang C, Liang C, Xu A, Cao Q, Wang Z

OncoTargets and Therapy 2017, 10:5805-5816

Published Date: 6 December 2017

The combination astemizole–gefitinib as a potential therapy for human lung cancer

Chávez-López MDG, Zúñiga-García V, Hernández-Gallegos E, Vera E, Chasiquiza-Anchatuña CA, Viteri-Yánez M, Sanchez-Ramos J, Garrido E, Camacho J

OncoTargets and Therapy 2017, 10:5795-5803

Published Date: 6 December 2017

CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway

Chen G, Shi Y, Zhang Y, Sun J

OncoTargets and Therapy 2017, 10:5783-5794

Published Date: 5 December 2017

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Zhong W, Zhang L, Ma J, Shao S, Lin R, Li X, Xiong G, Fang D, Zhou L

OncoTargets and Therapy 2017, 10:5775-5782

Published Date: 5 December 2017

Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis

Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV

OncoTargets and Therapy 2017, 10:5765-5774

Published Date: 4 December 2017

Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis

Gong L, Gu JC, Ge JW, Wu X, Zhang C, Yang C, Weng WJ, Gao GY, Feng JF, Mao Q

OncoTargets and Therapy 2017, 10:5755-5764

Published Date: 4 December 2017

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma

Qi X, Jia B, Zhao X, Yu D

OncoTargets and Therapy 2017, 10:5745-5754

Published Date: 1 December 2017

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

Huang L, Liu Q, Chen S, Shao ZM

OncoTargets and Therapy 2017, 10:5739-5744

Published Date: 1 December 2017

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma

Liao CC, Qin YY, Tan XH, Hu JJ, Tang Q, Rong Y, Cen H, Li LQ

OncoTargets and Therapy 2017, 10:5727-5738

Published Date: 30 November 2017

Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma

Zheng L, Chen K, Zhu L, Su D, Cheng G

OncoTargets and Therapy 2017, 10:5719-5726

Published Date: 29 November 2017

Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z, Lu M

OncoTargets and Therapy 2017, 10:5711-5718

Published Date: 28 November 2017

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo

Mori Y, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Hayashi D, Arai Y, Kishida T, Mazda O, Kubo T

OncoTargets and Therapy 2017, 10:5703-5710

Published Date: 28 November 2017

Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer

Wan L, Zhang L, Fan K, Wang JJ

OncoTargets and Therapy 2017, 10:5695-5702

Published Date: 28 November 2017

PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y

OncoTargets and Therapy 2017, 10:5685-5694

Published Date: 27 November 2017

MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA

Kang M, Shi J, Peng N, He S

OncoTargets and Therapy 2017, 10:5667-5675

Published Date: 28 November 2017

18F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma

An S, Zhou X, Liu J, Huang G

OncoTargets and Therapy 2017, 10:5643-5651

Published Date: 27 November 2017

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism

Markowitz D, Ha G, Ruggieri R, Symons M

OncoTargets and Therapy 2017, 10:5633-5642

Published Date: 24 November 2017

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer

Xie SY, Li G, Han C, Yu YY, Li N

OncoTargets and Therapy 2017, 10:5605-5619

Published Date: 23 November 2017

Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma

Feng SD, Mao ZM, Liu CY, Nie YS, Sun B, Guo MG, Su CQ

OncoTargets and Therapy 2017, 10:5591-5604

Published Date: 23 November 2017

Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma

Wang LY, Li JH, Zhou X, Zheng QC, Cheng X

OncoTargets and Therapy 2017, 10:5585-5589

Published Date: 22 November 2017

Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer

Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ

OncoTargets and Therapy 2017, 10:5575-5583

Published Date: 22 November 2017

The clinical significance of CXCL5 in non-small cell lung cancer

Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K

OncoTargets and Therapy 2017, 10:5561-5573

Published Date: 21 November 2017

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis

Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping WW, Wang M, Zhou CC, Wu R, Jia RP

OncoTargets and Therapy 2017, 10:5551-5559

Published Date: 22 November 2017

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ

Cui J, Chen S, Bo Q, Wang S, Zhang N, Yu M, Wang W, Han J, Zhu Y, Shi B

OncoTargets and Therapy 2017, 10:5541-5550

Published Date: 21 November 2017

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population

Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y

OncoTargets and Therapy 2017, 10:5525-5532

Published Date: 21 November 2017

The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

Velloso FJ, Bianco AFR, Farias JO, Torres NEC, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG

OncoTargets and Therapy 2017, 10:5491-5524

Published Date: 20 November 2017

Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma

Zheng L, Cao C, Cheng G, Hu Q, Chen X

OncoTargets and Therapy 2017, 10:5483-5487

Published Date: 16 November 2017

Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways

Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y

OncoTargets and Therapy 2017, 10:5471-5482

Published Date: 15 November 2017

Identification of COX5B as a novel biomarker in high-grade glioma patients

Hu T, Xi J

OncoTargets and Therapy 2017, 10:5463-5470

Published Date: 15 November 2017

Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X

OncoTargets and Therapy 2017, 10:5459-5462

Published Date: 14 November 2017

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L

OncoTargets and Therapy 2017, 10:5445-5458

Published Date: 14 November 2017

Clinical significance of CMTM4 expression in hepatocellular carcinoma

Bei CH, Zhang Y, Wei RM, Zhu XN, Wang ZG, Zeng W, Chen QY, Tan SK

OncoTargets and Therapy 2017, 10:5439-5443

Published Date: 14 November 2017

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Lu J, Li H, Guo P, Shen R, Luo Y, Ge Q, Shi WF, Li Y, Zhu W

OncoTargets and Therapy 2017, 10:5429-5437

Published Date: 13 November 2017

Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms

Ye X, Chen D, Zheng Y, Zhu X, Fu J, Huang J

OncoTargets and Therapy 2017, 10:5425-5428

Published Date: 13 November 2017

Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma

Zhang X, Ji J, Zhang G, Fang C, Jiang F, Ma S, Hou J

OncoTargets and Therapy 2017, 10:5417-5424

Published Date: 13 November 2017

In vitro study on anti-cancer properties of genistein in tongue cancer

Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L

OncoTargets and Therapy 2017, 10:5405-5415

Published Date: 13 November 2017

The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis

Chen X, Cheng J, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang X

OncoTargets and Therapy 2017, 10:5363-5375

Published Date: 10 November 2017

LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis

Wang Y, Huang YL, Xiang P, Tian W

OncoTargets and Therapy 2017, 10:5355-5361

Published Date: 9 November 2017

Amatuximab and novel agents targeting mesothelin for solid tumors

Baldo P, Cecco S

OncoTargets and Therapy 2017, 10:5337-5353

Published Date: 8 November 2017

Interleukin-6 upregulates SOX18 expression in osteosarcoma

Wu Z, Yang W, Liu J, Zhang F

OncoTargets and Therapy 2017, 10:5329-5336

Published Date: 8 November 2017

FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry

Wang Y, Bao X, Zhang Z, Sun Y, Zhou X

OncoTargets and Therapy 2017, 10:5317-5328

Published Date: 8 November 2017

Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database

Wang S, Gao W, Chen S, Bai L, Luo L, Zheng X, Luo Y

OncoTargets and Therapy 2017, 10:5311-5315

Published Date: 8 November 2017

UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis

Wang B, Shen J, Wang J

OncoTargets and Therapy 2017, 10:5303-5309

Published Date: 6 November 2017

The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population

Hu J, Dong D, Lu DD

OncoTargets and Therapy 2017, 10:5297-5302

Published Date: 6 November 2017

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients

Liu XJ, Song YC, Liang P, Su TS, Zhang HJ, Zhao XZ, Yuan ZY, Wang P

OncoTargets and Therapy 2017, 10:5289-5295

Published Date: 6 November 2017

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells

Guo L, Huang S, Wang X

OncoTargets and Therapy 2017, 10:5281-5288

Published Date: 3 November 2017

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N

OncoTargets and Therapy 2017, 10:5273-5279

Published Date: 2 November 2017

Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis

Wu N, Zhang X, Tian J, Yu S, Qiao Y

OncoTargets and Therapy 2017, 10:5263-5271

Published Date: 2 November 2017

Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma

Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ

OncoTargets and Therapy 2017, 10:5255-5261

Published Date: 2 November 2017

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH

OncoTargets and Therapy 2017, 10:5237-5242

Published Date: 1 November 2017

MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis

Liu H, Li P, Chen L, Jian C, Li ZH, Yu AX

OncoTargets and Therapy 2017, 10:5229-5236

Published Date: 1 November 2017

Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis

Gao XL, Zhang M, Tang YL, Liang XH

OncoTargets and Therapy 2017, 10:5219-5228

Published Date: 27 October 2017

Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition

Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z

OncoTargets and Therapy 2017, 10:5209-5217

Published Date: 27 October 2017

Current status of poly(ADP-ribose) polymerase inhibitors and future directions

Ohmoto A, Yachida S

OncoTargets and Therapy 2017, 10:5195-5208

Published Date: 26 October 2017

The expression profile and clinical significance of circRNA0003906 in colorectal cancer

Zhuo F, Lin HS, Chen ZX, Huang ZJ, Hu JP

OncoTargets and Therapy 2017, 10:5187-5193

Published Date: 25 October 2017

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer

Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S

OncoTargets and Therapy 2017, 10:5179-5186

Published Date: 25 October 2017

Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer

Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC

OncoTargets and Therapy 2017, 10:5173-5177

Published Date: 25 October 2017

Low-grade central osteosarcoma in proximal humerus: a rare entity

Tang F, Min L, Zhou Y, Luo Y, Tu CQ

OncoTargets and Therapy 2017, 10:5165-5172

Published Date: 24 October 2017

Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells

Zhou X, Xiong ZJ, Xiao SM, Zhou J, Ding Z, Tang LC, Chen XD, Xu R, Zhao P

OncoTargets and Therapy 2017, 10:5151-5163

Published Date: 24 October 2017

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis

Wang P, Chen D, Ma H, Li Y

OncoTargets and Therapy 2017, 10:5137-5149

Published Date: 25 October 2017

Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma

Lin X, Cai L, Qian Z, Wang C, Sun N, Sun X, Huang H, Guo W, Lin H, Yao R

OncoTargets and Therapy 2017, 10:5129-5136

Published Date: 24 October 2017

Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7

Chen KL, Li L, Wang YR, Li CM, Badri TM, Wang GL

OncoTargets and Therapy 2017, 10:5115-5128

Published Date: 24 October 2017

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer

Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T

OncoTargets and Therapy 2017, 10:5107-5113

Published Date: 24 October 2017

The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study

Schiegnitz E, Kämmerer PW, Schön H, Gülle C, Berres M, Sagheb K, Al-Nawas B

OncoTargets and Therapy 2017, 10:5099-5105

Published Date: 24 October 2017

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports

Xie HJ, Xie B, Liu CY, Wang J, Xu Y

OncoTargets and Therapy 2017, 10:5089-5097

Published Date: 24 October 2017

Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite

Zhou Y, Zhang GY, Wang F, Wang J, Ding YW, Li XY, Shi CT, Li JK, Shih CK, You S

OncoTargets and Therapy 2017, 10:5077-5087

Published Date: 20 October 2017

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R

OncoTargets and Therapy 2017, 10:5065-5076

Published Date: 19 October 2017

Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts

Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C

OncoTargets and Therapy 2017, 10:5047-5051

Published Date: 19 October 2017

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R

OncoTargets and Therapy 2017, 10:5013-5030

Published Date: 16 October 2017

Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis

Zhuan-Sun Y, Huang F, Feng M, Zhao X, Chen W, Zhu Z, Zhang S

OncoTargets and Therapy 2017, 10:5005-5012

Published Date: 16 October 2017

Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients

Bhandari A, Wang Y, Lv S, Xia E, Wang O

OncoTargets and Therapy 2017, 10:4997-5004

Published Date: 16 October 2017

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:4989-4995

Published Date: 13 October 2017

Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression

Vikberg AL, Vooder T, Lokk K, Annilo T, Golovleva I

OncoTargets and Therapy 2017, 10:4969-4979

Published Date: 11 October 2017

Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population

Trachu N, Sirachainan E, Larbcharoensub N, Rattanadech W, Detarkom S, Monnamo N, Kamprerasart K, MunTham D, Sukasem C, Reungwetwattana T

OncoTargets and Therapy 2017, 10:4955-4968

Published Date: 11 October 2017

Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer

Zhang C, Liu C, Wu J, Zheng Y, Xu H, Cheng G, Hua L

OncoTargets and Therapy 2017, 10:4945-4954

Published Date: 11 October 2017

The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance

Zhang H, Sun Y, Li J, Huang L, Tan S, Yang F, Li H

OncoTargets and Therapy 2017, 10:4935-4943

Published Date: 11 October 2017

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2

Ding N, Wu H, Tao T, Peng E

OncoTargets and Therapy 2017, 10:4905-4915

Published Date: 6 October 2017

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K

OncoTargets and Therapy 2017, 10:4885-4893

Published Date: 6 October 2017

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Song F, Zhang J, Li S, Wu J, Jin T, Qin J, Wang Y, Wang M, Xu J

OncoTargets and Therapy 2017, 10:4859-4867

Published Date: 3 October 2017

TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma

Lee HW, Park W, Heo Y, Park TI, Park SY, Lee J

OncoTargets and Therapy 2017, 10:4853-4858

Published Date: 3 October 2017

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

Shi T, Jiang R, Wang P, Xu Y, Yin S, Cheng X, Zang R

OncoTargets and Therapy 2017, 10:4841-4851

Published Date: 3 October 2017

Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis

Zhang M, Ma H, Zhang J, He L, Ye X, Li X

OncoTargets and Therapy 2017, 10:4829-4839

Published Date: 3 October 2017

Theranostics in nuclear medicine practice

Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M

OncoTargets and Therapy 2017, 10:4821-4828

Published Date: 3 October 2017

Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y

OncoTargets and Therapy 2017, 10:4809-4819

Published Date: 3 October 2017

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?

Rabinowits G

OncoTargets and Therapy 2017, 10:4803-4807

Published Date: 28 September 2017

Clinicopathological features and prognoses in younger and older patients with gastric cancer

Song S, Li C, Li S, Cong X, Xue Y

OncoTargets and Therapy 2017, 10:4795-4802

Published Date: 27 September 2017

Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinoma

Chen P, Song Q, Han J, Xu H, Chen T, Xu J, Cheng Y

OncoTargets and Therapy 2017, 10:4787-4794

Published Date: 27 September 2017

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience

Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, Enkirch SJ, Essler M, Spengler U, Schild HH

OncoTargets and Therapy 2017, 10:4773-4785

Published Date: 26 September 2017

Molecular classification of esophagogastric junction carcinoma correlated with prognosis

Zou L, Wu Y, Ma K, Fan Y, Dong D, Geng N, Li E

OncoTargets and Therapy 2017, 10:4765-4772

Published Date: 25 September 2017

HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a

Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X

OncoTargets and Therapy 2017, 10:4753-4763

Published Date: 28 September 2017

DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma

Huang J, Tan ZR, Yu J, Li H, Lv Q, Shao Y, Zhou H

OncoTargets and Therapy 2017, 10:4739-4751

Published Date: 26 September 2017

Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors

Xu PP, Guo D, Shao XY, Peng MX, Chen B

OncoTargets and Therapy 2017, 10:4731-4738

Published Date: 25 September 2017

Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors

Ma Z, Huang H, Xu Y, He X, Wang J, Hui B, Ji H, Zhou J, Wang K

OncoTargets and Therapy 2017, 10:4711-4717

Published Date: 25 September 2017

RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2

Jiang L, Xu G, Li Z, Zeng X, Li Z, Liu J, Mei L, Li X

OncoTargets and Therapy 2017, 10:4701-4709

Published Date: 25 September 2017

High expression of Sam68 in sacral chordomas is associated with worse clinical outcomes

Wen H, Li P, Ma H, Zheng J, Yu Y, Lv G

OncoTargets and Therapy 2017, 10:4691-4700

Published Date: 22 September 2017

Targeting the androgen receptor in triple-negative breast cancer: current perspectives

Mina A, Yoder R, Sharma P

OncoTargets and Therapy 2017, 10:4675-4685

Published Date: 20 September 2017

Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT

Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G

OncoTargets and Therapy 2017, 10:4665-4673

Published Date: 20 September 2017

DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy

Carloni S, Gallerani G, Tesei A, Scarpi E, Verdecchia GM, Virzì S, Fabbri F, Arienti C

OncoTargets and Therapy 2017, 10:4657-4664

Published Date: 20 September 2017

The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis

Pang Q, Jin H, Qu K, Man Z, Wang Y, Yang S, Zhou L, Liu H

OncoTargets and Therapy 2017, 10:4645-4656

Published Date: 20 September 2017

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma

Maroto P, Esteban E, Fernández Parra E, Mendez-Vidal MJ, Domenech M, Pérez-Valderrama B, Calderero V, Pérez-Gracia JL, Grande E, Algaba F

OncoTargets and Therapy 2017, 10:4635-4643

Published Date: 20 September 2017

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH

OncoTargets and Therapy 2017, 10:4625-4633

Published Date: 19 September 2017

EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma

Memon AA, Zhang HP, Gu Y, Luo Q, Shi JJ, Deng Z, Ma J, Ma W

OncoTargets and Therapy 2017, 10:4607-4613

Published Date: 18 September 2017

Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy

Sunakawa Y, Izawa N, Mizukami T, Horie Y, Hirakawa M, Arai H, Ogura T, Tsuda T, Nakajima TE

OncoTargets and Therapy 2017, 10:4599-4605

Published Date: 15 September 2017

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis

Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X

OncoTargets and Therapy 2017, 10:4591-4598

Published Date: 15 September 2017

Polygonatum odoratum lectin promotes BECN1 expression and induces autophagy in malignant melanoma by regulation of miR1290

Luan W, Qian Y, Ni X, Chanda TK, Xia Y, Wang J, Yan Y, Xu B

OncoTargets and Therapy 2017, 10:4569-4577

Published Date: 14 September 2017

CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study

Al-Mukaynizi FB, Alanazi M, Al-Daihan S, Parine NR, Almadi M, Aljebreen A, Azzam N, Alharbi O, Arafah M, Warsy A

OncoTargets and Therapy 2017, 10:4559-4567

Published Date: 14 September 2017

Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy

Luo C, Shen JY, Ying J, Fang XH, Wang XH, Fu ZX, Liu P

OncoTargets and Therapy 2017, 10:4553-4557

Published Date: 14 September 2017

Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis

Ge H, He X, Guo L, Yang X

OncoTargets and Therapy 2017, 10:4543-4551

Published Date: 13 September 2017

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

Muller IB, de Langen AJ, Giovannetti E, Peters GJ

OncoTargets and Therapy 2017, 10:4535-4541

Published Date: 13 September 2017

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G

OncoTargets and Therapy 2017, 10:4527-4534

Published Date: 12 September 2017

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Yu S, Zhang Y, Pan YJ, Cheng C, Sun YH, Chen HQ

OncoTargets and Therapy 2017, 10:4507-4515

Published Date: 12 September 2017

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T

OncoTargets and Therapy 2017, 10:4493-4506

Published Date: 12 September 2017

Predictive factors and prognosis for recurrent laryngeal nerve invasion in papillary thyroid carcinoma

Chen W, Lei J, You J, Lei Y, Li Z, Gong R, Tang H, Zhu J

OncoTargets and Therapy 2017, 10:4485-4491

Published Date: 11 September 2017

Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis

Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, Wang Z, Li D, Ning C, Sun C

OncoTargets and Therapy 2017, 10:4475-4483

Published Date: 11 September 2017

Oncogenic role of microRNA-20a in human multiple myeloma

Wang T, Tao W, Zhang L, Li SL

OncoTargets and Therapy 2017, 10:4465-4474

Published Date: 11 September 2017

miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells

Li X, Li Y, Wan L, Chen R, Chen F

OncoTargets and Therapy 2017, 10:4455-4464

Published Date: 11 September 2017

Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma

Wang Y, Liu Y, Wang X, Li X, Jiang R, He X

OncoTargets and Therapy 2017, 10:4435-4441

Published Date: 11 September 2017

Prognostic immune-related gene models for breast cancer: a pooled analysis

Zhao J, Wang Y, Lao Z, Liang S, Hou J, Yu Y, Yao H, You N, Chen K

OncoTargets and Therapy 2017, 10:4423-4433

Published Date: 11 September 2017

Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer

Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W

OncoTargets and Therapy 2017, 10:4413-4422

Published Date: 11 September 2017

Marketed drugs used for the management of hypercholesterolemia as anticancer armament

Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A

OncoTargets and Therapy 2017, 10:4393-4411

Published Date: 8 September 2017

Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway

Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z

OncoTargets and Therapy 2017, 10:4379-4391

Published Date: 8 September 2017

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population

Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M, Wang C

OncoTargets and Therapy 2017, 10:4369-4378

Published Date: 7 September 2017

Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia

Weagel EG, Meng W, Townsend MH, Velazquez EJ, Brog RA, Boyer MW, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:4355-4367

Published Date: 6 September 2017

Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report

Jovanovic D, Stevic R, Velinovic M, Kontic M, Maric D, Spasic J, Radosavljevic D

OncoTargets and Therapy 2017, 10:4347-4354

Published Date: 6 September 2017

Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells

Asari Y, Kageyama K, Nakada Y, Tasso M, Takayasu S, Niioka K, Ishigame N, Daimon M

OncoTargets and Therapy 2017, 10:4329-4338

Published Date: 1 September 2017

The role and significance of VEGFR2+ regulatory T cells in tumor immunity

Zhu PR, Hu CX, Hui KY, Jiang XD

OncoTargets and Therapy 2017, 10:4315-4319

Published Date: 1 September 2017

Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2

Yang TQ, Chen M, Wang YQ, Xu W, Han Y, Xu J, Xiang YJ, Yuan B, Wang HZ, Zhou YX

OncoTargets and Therapy 2017, 10:4305-4313

Published Date: 31 August 2017

Improvement of survival for non-small cell lung cancer over time

Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, Chen B, Ma W, Xu L, Jiang F

OncoTargets and Therapy 2017, 10:4295-4303

Published Date: 29 August 2017

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M

OncoTargets and Therapy 2017, 10:4273-4281

Published Date: 28 August 2017

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation

Zeng D, Wang C, Huang J, Jiang J

OncoTargets and Therapy 2017, 10:4269-4272

Published Date: 28 August 2017

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q

OncoTargets and Therapy 2017, 10:4261-4267

Published Date: 28 August 2017

LEF1-AS1, a long non-coding RNA, promotes malignancy in glioblastoma

Wang J, Liu X, Yan C, Liu J, Wang S, Hong Y, Gu A, Zhao P

OncoTargets and Therapy 2017, 10:4251-4260

Published Date: 28 August 2017

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ

OncoTargets and Therapy 2017, 10:4239-4250

Published Date: 29 August 2017

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples

Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I

OncoTargets and Therapy 2017, 10:4225-4238

Published Date: 28 August 2017

HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer

Cao S, Sun J, Lin S, Zhao L, Wu D, Liang T, Sheng W

OncoTargets and Therapy 2017, 10:4205-4211

Published Date: 26 August 2017

Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10

Chu H, Jia B, Qiu X, Pan J, Sun X, Wang Z, Zhao J

OncoTargets and Therapy 2017, 10:4193-4203

Published Date: 29 August 2017

miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer

Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, Wang X, Xia M, Zuo C

OncoTargets and Therapy 2017, 10:4161-4171

Published Date: 22 August 2017

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells

Lee D, Yu EJ, Ham I, Hur H, Kim Y

OncoTargets and Therapy 2017, 10:4153-4159

Published Date: 22 August 2017

RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia

Liu F, Gong M, Gao L, Cai X, Zhang H, Ma Y

OncoTargets and Therapy 2017, 10:4143-4151

Published Date: 22 August 2017

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P

OncoTargets and Therapy 2017, 10:4129-4133

Published Date: 21 August 2017

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Chen Y, Tang W, Pan X, Wu C, Cao Y, Yang W

OncoTargets and Therapy 2017, 10:4113-4119

Published Date: 17 August 2017

Chest reconstruction using a custom-designed polyethylene 3D implant after resection of the sternal manubrium

Lipińska J, Kutwin L, Wawrzycki M, Olbrzymek L, Jabłoński S

OncoTargets and Therapy 2017, 10:4099-4103

Published Date: 17 August 2017

CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy

Tong L, Liu P, Huo B, Guo Z, Ni H

OncoTargets and Therapy 2017, 10:4081-4088

Published Date: 17 August 2017

Carcinogenicity of chromium and chemoprevention: a brief update

Wang Y, Su H, Gu Y, Song X, Zhao J

OncoTargets and Therapy 2017, 10:4065-4079

Published Date: 16 August 2017

The role of desmosomes in carcinogenesis

Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T

OncoTargets and Therapy 2017, 10:4059-4063

Published Date: 14 August 2017

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer

Lv RB, Wang QG, Liu C, Liu F, Zhao Q, Han JG, Ren DL, Liu B, Li CL

OncoTargets and Therapy 2017, 10:4051-4057

Published Date: 14 August 2017

An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma

Huang CG, Yuan NJ, Wu LY, Wang XF, Dai JQ, Song P, Li FX, Xu CB, Zhao XH

OncoTargets and Therapy 2017, 10:4037-4050

Published Date: 14 August 2017

Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells

Liu Y, Tang Z, Yang J, Zhou Y, Meng L, Wang H, Li C

OncoTargets and Therapy 2017, 10:4023-4028

Published Date: 11 August 2017

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy

Chen L, Hao Y, Zhu LH, Li S, Zuo YJ, Zhang YX, Song HJ, Xue YW

OncoTargets and Therapy 2017, 10:4007-4016

Published Date: 10 August 2017

Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen

Shibaguchi H, Luo N, Shirasu N, Kuroki M, Kuroki M

OncoTargets and Therapy 2017, 10:3979-3990

Published Date: 22 August 2017

Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells

Liang J, Gao W, Cai L

OncoTargets and Therapy 2017, 10:3971-3978

Published Date: 7 August 2017

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma

Li J, Wang L

OncoTargets and Therapy 2017, 10:3965-3969

Published Date: 7 August 2017

Therapies for acute myeloid leukemia: vosaroxin

Sayar H, Bashardoust P

OncoTargets and Therapy 2017, 10:3957-3963

Published Date: 7 August 2017

Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target

Sun M, Zhao W, Zeng Y, Zhang D, Chen Z, Liu C, Wu B

OncoTargets and Therapy 2017, 10:3949-3956

Published Date: 7 August 2017

NRAS-mutant melanoma: current challenges and future prospect

Muñoz-Couselo E, Zamora Adelantado E, Ortiz C, Soberino García J, Perez-Garcia J

OncoTargets and Therapy 2017, 10:3941-3947

Published Date: 8 August 2017

Bystander signaling via oxidative metabolism

Sawal HA, Asghar K, Bureik M, Jalal N

OncoTargets and Therapy 2017, 10:3925-3940

Published Date: 4 August 2017

Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer

Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY

OncoTargets and Therapy 2017, 10:3917-3924

Published Date: 4 August 2017

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer

Zhou Y, Li R, Yu H, Wang R, Shen Z

OncoTargets and Therapy 2017, 10:3893-3905

Published Date: 3 August 2017

SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo

Hu ZQ, Li J, Gao Q, Wei S, Yang B

OncoTargets and Therapy 2017, 10:3881-3891

Published Date: 2 August 2017

A practical guide to the handling and administration of talimogene laherparepvec in Europe

Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R

OncoTargets and Therapy 2017, 10:3867-3880

Published Date: 2 August 2017

IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia

Zhang JJ, Ji Q, Jiao CH, Ren LH, Zhao Y, Chen YF, Shi RH, Feng YD

OncoTargets and Therapy 2017, 10:3861-3866

Published Date: 1 August 2017

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

Lan XW, Xiao Y, Zou XB, Zhang XM, OuYang PY, Xie FY

OncoTargets and Therapy 2017, 10:3853-3860

Published Date: 1 August 2017

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J

OncoTargets and Therapy 2017, 10:3843-3851

Published Date: 1 August 2017

The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT

Sun HL, Ni JY, Jiang XY, Chen D, Chen YT, Xu LF

OncoTargets and Therapy 2017, 10:3835-3842

Published Date: 1 August 2017

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma

Dong X, Guo W, Zhang S, Wu T, Sun Z, Yan S, Zheng S

OncoTargets and Therapy 2017, 10:3827-3833

Published Date: 31 July 2017

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer

Roviello G, Corona SP, Bonetta A, Cappelletti MR, Generali D

OncoTargets and Therapy 2017, 10:3811-3815

Published Date: 31 July 2017

MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects

Hua WF, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z

OncoTargets and Therapy 2017, 10:3773-3780

Published Date: 27 July 2017

Volumetric modulated arc therapy for treatment of solid tumors: current insights

Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G

OncoTargets and Therapy 2017, 10:3755-3772

Published Date: 26 July 2017

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity

Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai Y, Xu X, Zhang Y, Wang MR

OncoTargets and Therapy 2017, 10:3743-3754

Published Date: 26 July 2017

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma

Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, You B, You Y

OncoTargets and Therapy 2017, 10:3733-3741

Published Date: 24 July 2017

Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma

Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T

OncoTargets and Therapy 2017, 10:3719-3732

Published Date: 24 July 2017

The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies

Hu J, Wu C, Zhao X, Liu C

OncoTargets and Therapy 2017, 10:3709-3718

Published Date: 24 July 2017

miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis

Ye H, Hao H, Wang J, Chen R, Huang Z

OncoTargets and Therapy 2017, 10:3685-3696

Published Date: 21 July 2017

Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study

Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH

OncoTargets and Therapy 2017, 10:3667-3683

Published Date: 20 July 2017

Clinical targeting recombinant immunotoxins for cancer therapy

Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P

OncoTargets and Therapy 2017, 10:3645-3665

Published Date: 20 July 2017

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia

Guo H, Zhang T, Wen X, Zhou JD, Ma J, An C, Zhang W, Xu Z, Lin J, Qian J

OncoTargets and Therapy 2017, 10:3635-3644

Published Date: 20 July 2017

Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis

Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z

OncoTargets and Therapy 2017, 10:3625-3634

Published Date: 21 July 2017

Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells

Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM

OncoTargets and Therapy 2017, 10:3607-3616

Published Date: 19 July 2017

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2017, 10:3579-3589

Published Date: 19 July 2017

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab

Queudeville M, Handgretinger R, Ebinger M

OncoTargets and Therapy 2017, 10:3567-3578

Published Date: 19 July 2017

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer

Pan HW, Su HH, Hsu C, Huang GJ, Wu TT

OncoTargets and Therapy 2017, 10:3531-3543

Published Date: 17 July 2017

Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells

Li J, Zhen L, Zhang Y, Zhao L, Liu H, Cai D, Chen H, Yu J, Qi X, Li G

OncoTargets and Therapy 2017, 10:3521-3529

Published Date: 17 July 2017

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V

OncoTargets and Therapy 2017, 10:3501-3513

Published Date: 17 July 2017

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy

Zhou CC, Zhang J, Chen Y, Wang H, Hou JQ

OncoTargets and Therapy 2017, 10:3485-3491

Published Date: 14 July 2017

Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways

Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H

OncoTargets and Therapy 2017, 10:3467-3474

Published Date: 13 July 2017

PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells

Kumar R, Yu F, Zhen YH, Li B, Wang J, Yang Y, Ge HX, Hu P, Xiu J

OncoTargets and Therapy 2017, 10:3453-3465

Published Date: 13 July 2017

Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition

He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX

OncoTargets and Therapy 2017, 10:3435-3451

Published Date: 12 July 2017

Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases

Liu H, Zhou M

OncoTargets and Therapy 2017, 10:3429-3434

Published Date: 12 July 2017

RNA sequencing identifies gene expression profile changes associated with β-estradiol treatment in U2OS osteosarcoma cells

Chen B, Liu Z, Zhang J, Wang H, Yu B

OncoTargets and Therapy 2017, 10:3421-3427

Published Date: 11 July 2017

A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma

Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ

OncoTargets and Therapy 2017, 10:3405-3419

Published Date: 11 July 2017

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

Mao Y, Wu S

OncoTargets and Therapy 2017, 10:3399-3404

Published Date: 11 July 2017

Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study

Wei Y, Wu YP, Xu N, Li XD, Chen SH, Cai H, Zheng QS, Xue XY

OncoTargets and Therapy 2017, 10:3381-3389

Published Date: 10 July 2017

The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia

Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A

OncoTargets and Therapy 2017, 10:3373-3380

Published Date: 10 July 2017

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M

OncoTargets and Therapy 2017, 10:3363-3372

Published Date: 10 July 2017

The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer

Chen ZL, Liu H, Yang HL, Gao YK, Zhang GW, Hu JJ

OncoTargets and Therapy 2017, 10:3353-3362

Published Date: 10 July 2017

Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer

Guo Y, Shi JJ, Zhang J, Li HX, Liu B, Guo H

OncoTargets and Therapy 2017, 10:3337-3344

Published Date: 7 July 2017

Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells

Woitok M, Klose D, Di Fiore S, Richter W, Stein C, Gresch G, Grieger E, Barth S, Fischer R, Kolberg K, Niesen J

OncoTargets and Therapy 2017, 10:3313-3327

Published Date: 6 July 2017

Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC

Wu Y, Tong R, Zhang Y, Hu B, Zheng K, Ding Z, Peng F, Gong Y, Liu Y, Lu Y

OncoTargets and Therapy 2017, 10:3307-3312

Published Date: 5 July 2017

Novel agents for the treatment of childhood leukemia: an update

Eryılmaz E, Canpolat C

OncoTargets and Therapy 2017, 10:3299-3306

Published Date: 4 July 2017

Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells

Chang YT, Huang C, Tang J, Liaw C, Li R, Liu J, Sheu J, Chang HW

OncoTargets and Therapy 2017, 10:3289-3297

Published Date: 4 July 2017

Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors

Han T, Yang X, Xu Y, Zheng Z, Yan Y, Wang N

OncoTargets and Therapy 2017, 10:3277-3283

Published Date: 3 July 2017

The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases

Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y

OncoTargets and Therapy 2017, 10:3261-3276

Published Date: 3 July 2017

Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy

Wu C, Zhu X, Liu W, Ruan T, Tao K

OncoTargets and Therapy 2017, 10:3249-3259

Published Date: 30 June 2017

LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism

Ding G, Peng Z, Shang J, Kang Y, Ning HB, Mao CS

OncoTargets and Therapy 2017, 10:3241-3247

Published Date: 30 June 2017

Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02

Huang YD, Hong XL, Hu J, Lu Q

OncoTargets and Therapy 2017, 10:3233-3239

Published Date: 29 June 2017

Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles

Zhang X, Sun YY, Wang P, Yang CF, Li SW

OncoTargets and Therapy 2017, 10:3225-3232

Published Date: 29 June 2017

CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells

Wang M, Lin T, Wang YC, Gao S, Yang ZY, Hong X, Chen GY

OncoTargets and Therapy 2017, 10:3215-3224

Published Date: 29 June 2017

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Shimada M, Fukuda M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H

OncoTargets and Therapy 2017, 10:3211-3214

Published Date: 29 June 2017

Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies

Zhao YN, Zheng X, Zhang LJ, Hu Q, Guo YT, Jiang H, Shi SN, Zhang X

OncoTargets and Therapy 2017, 10:3203-3210

Published Date: 29 June 2017

The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis

Zhang YF, Lin JB, Huang WJ, Cao Y, Liu Y, Wang TQ, Zhong WY, Wang DL, Mao RR, Chen XL

OncoTargets and Therapy 2017, 10:3193-3201

Published Date: 28 June 2017

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M

OncoTargets and Therapy 2017, 10:3187-3192

Published Date: 27 June 2017

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM

OncoTargets and Therapy 2017, 10:3177-3186

Published Date: 27 June 2017

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J

OncoTargets and Therapy 2017, 10:3169-3175

Published Date: 27 June 2017

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo

Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S

OncoTargets and Therapy 2017, 10:3131-3144

Published Date: 26 June 2017

The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis

Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H

OncoTargets and Therapy 2017, 10:3123-3130

Published Date: 22 June 2017

Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer

Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, Qu Y, Jiang Z, Han J, Cheng Y

OncoTargets and Therapy 2017, 10:3107-3118

Published Date: 21 June 2017

Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy

Bai Y, Wu HW, Ma X, Liu Y, Zhang YH

OncoTargets and Therapy 2017, 10:3071-3081

Published Date: 19 June 2017

The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis

Xu H, Ma Y, Deng F, Ju W, Sun X, Wang H

OncoTargets and Therapy 2017, 10:3059-3070

Published Date: 19 June 2017

Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma

Aigner KR, Selak E, Gailhofer S

OncoTargets and Therapy 2017, 10:3049-3057

Published Date: 19 June 2017

Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma

Ni W, Song E, Gong M, Li Y, Yao J, An R

OncoTargets and Therapy 2017, 10:3039-3047

Published Date: 19 June 2017

Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer

Dockery LE, Gunderson CC, Moore KN

OncoTargets and Therapy 2017, 10:3029-3037

Published Date: 19 June 2017

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts

De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P

OncoTargets and Therapy 2017, 10:3007-3015

Published Date: 16 June 2017

Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy

Feng M, Tang C, Feng W, Bao Y, Zheng Y, Shen J

OncoTargets and Therapy 2017, 10:3001-3005

Published Date: 14 June 2017

Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells

Yang Y, Yin W, Wu FY, Fan J

OncoTargets and Therapy 2017, 10:2993-2999

Published Date: 14 June 2017

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

Chang H, Kim JS, Choi YJ, Cho J, Woo J, Kim A, Kim JS, Kang EJ

OncoTargets and Therapy 2017, 10:2983-2992

Published Date: 13 June 2017

Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials

Liu YY, Kou CG, Su YY, Zhang YY, You YY, Zhang LL, Wang MH, Fu YL, Ren XJ, Yang YM

OncoTargets and Therapy 2017, 10:2971-2981

Published Date: 13 June 2017

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy

de Groot S, Gelderblom H, Fiocco M, Bovée JVMG, van der Hoeven JJM, Pijl H, Kroep JR

OncoTargets and Therapy 2017, 10:2963-2970

Published Date: 13 June 2017

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis

Kan HC, Hou CP, Lin YH, Tsui KH, Chang PL, Chen CL

OncoTargets and Therapy 2017, 10:2943-2949

Published Date: 12 June 2017

Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma

Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2923-2930

Published Date: 9 June 2017

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K

OncoTargets and Therapy 2017, 10:2903-2908

Published Date: 9 June 2017

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis

Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, Zhang L, Zhan C, Feng M, Wang Q

OncoTargets and Therapy 2017, 10:2885-2892

Published Date: 7 June 2017

PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy

Liu H, Zhang L, Zhang X, Cui Z

OncoTargets and Therapy 2017, 10:2865-2871

Published Date: 6 June 2017

Prognostic value of high IMP3 expression in solid tumors: a meta-analysis

Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X

OncoTargets and Therapy 2017, 10:2849-2863

Published Date: 6 June 2017

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma

Bai X, Li Y, Zhang H, Wang F, He H, Yao J, Liu L, Li S

OncoTargets and Therapy 2017, 10:2837-2847

Published Date: 2 June 2017

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]

Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2017, 10:2835-2836

Published Date: 2 June 2017

SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma

Huang W, Huang H, Wang L, Hu J, Song W

OncoTargets and Therapy 2017, 10:2825-2833

Published Date: 2 June 2017

Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer

Zhan XH, Dong C, Liu G, Li YX, Liu L

OncoTargets and Therapy 2017, 10:2805-2813

Published Date: 1 June 2017

Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy

Chen L, Li Z, Zhang Q, Wei S, Li B, Zhang X, Zhang L, Li Q, Xu H, Xu Z

OncoTargets and Therapy 2017, 10:2791-2804

Published Date: 1 June 2017

The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma

Wang X, Wang S, Li X, Jin S, Xiong F, Wang X

OncoTargets and Therapy 2017, 10:2781-2789

Published Date: 31 May 2017

The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism

Chen L, Sun L, Dong L, Cui P, Xia Z, Li C, Zhu Y

OncoTargets and Therapy 2017, 10:2769-2778

Published Date: 30 May 2017

The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma

Song G, Jing W, Xue S, Guo H, Yu J

OncoTargets and Therapy 2017, 10:2729-2736

Published Date: 25 May 2017

Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma

Kwon NS, Kim DS, Yun HY

OncoTargets and Therapy 2017, 10:2721-2728

Published Date: 24 May 2017

Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials

Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Chaiyakunapruk N

OncoTargets and Therapy 2017, 10:2689-2700

Published Date: 23 May 2017

Ezh2, a novel target in detection and therapy of breast cancer

Pourakbar S, Pluard TJ, Accurso AD, Farassati F

OncoTargets and Therapy 2017, 10:2685-2687

Published Date: 22 May 2017

Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer

Shao Y, Zhu W, Da J, Xu M, Wang Y, Zhou J, Wang Z

OncoTargets and Therapy 2017, 10:2675-2683

Published Date: 22 May 2017

Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer

Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S

OncoTargets and Therapy 2017, 10:2665-2673

Published Date: 22 May 2017

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation

Pang X, Li Q, Ma Z, Shi Y, Ma Y, Li X, Cui W, Zhang W

OncoTargets and Therapy 2017, 10:2645-2654

Published Date: 19 May 2017

The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer

Yang B, Luo TH, Zhang MJ, Lu ZM, Xue XC, Fang GN

OncoTargets and Therapy 2017, 10:2635-2643

Published Date: 18 May 2017

FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis

Liu Y, Zheng Z, Zhang QX, Zhou XL, Feng YK, Yan AQ

OncoTargets and Therapy 2017, 10:2621-2633

Published Date: 18 May 2017

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y, Zhou S, Wang X, Xu J, Tao R

OncoTargets and Therapy 2017, 10:2595-2600

Published Date: 17 May 2017

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia

Meier-Stephenson V, Riemer J, Narendran A

OncoTargets and Therapy 2017, 10:2581-2593

Published Date: 16 May 2017

Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

Chen L, Zuo YJ, Zhu LH, Zhang YX, Li S, Ma F, Han Y, Song HJ, Xue YW

OncoTargets and Therapy 2017, 10:2569-2580

Published Date: 17 May 2017

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

Du E, Wang L, Li C, Zhang C, Qu Y, Liu R, Xu Y, Yang K, Zhang Z

OncoTargets and Therapy 2017, 10:2561-2567

Published Date: 15 May 2017

Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients

Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:2553-2560

Published Date: 15 May 2017

MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein

Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W

OncoTargets and Therapy 2017, 10:2527-2538

Published Date: 11 May 2017

Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis

Wang F, Li H, Long J, Ye S

OncoTargets and Therapy 2017, 10:2491-2499

Published Date: 8 May 2017

Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

Batson S, Mitchell SA, Windisch R, Damonte E, Munk VC, Reguart N

OncoTargets and Therapy 2017, 10:2473-2482

Published Date: 5 May 2017

An isolated unusual digit metastasis from esophageal carcinoma: a case report

Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J

OncoTargets and Therapy 2017, 10:2449-2452

Published Date: 9 May 2017

Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide

Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR

OncoTargets and Therapy 2017, 10:2427-2447

Published Date: 4 May 2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

OncoTargets and Therapy 2017, 10:2425-2426

Published Date: 4 May 2017

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response

Sun WW, Xu ZH, Lian P, Gao BL, Hu JA

OncoTargets and Therapy 2017, 10:2413-2424

Published Date: 4 May 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:2411-2412

Published Date: 3 May 2017

The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis

Huang GJ, Luo MS, Zhang JX, Liu HB

OncoTargets and Therapy 2017, 10:2403-2410

Published Date: 3 May 2017

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M

OncoTargets and Therapy 2017, 10:2389-2401

Published Date: 2 May 2017

Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells

Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G

OncoTargets and Therapy 2017, 10:2377-2388

Published Date: 2 May 2017

Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2

Liu W, Yu Q, Ma J, Cheng Y, Zhang H, Luo W, Yao J, Zhang H

OncoTargets and Therapy 2017, 10:2367-2376

Published Date: 2 May 2017

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]

Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi M, Sachchidanand, Parine NR, Chourasia M

OncoTargets and Therapy 2017, 10:2365-2366

Published Date: 28 April 2017

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies

Ilcus C, Bagacean C, Tempescul A, Popescu C, Parvu A, Cenariu M, Bocsan C, Zdrenghea M

OncoTargets and Therapy 2017, 10:2349-2363

Published Date: 28 April 2017

No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations

Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:2325-2333

Published Date: 27 April 2017

Role of CT scan in differentiating the type of colorectal cancer

Li ZH, You DY, Gao DP, Yang GJ, Dong XX, Zhang DF, Ding YY

OncoTargets and Therapy 2017, 10:2297-2303

Published Date: 26 April 2017

Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report

Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q

OncoTargets and Therapy 2017, 10:2289-2295

Published Date: 26 April 2017

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection

Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM

OncoTargets and Therapy 2017, 10:2257-2266

Published Date: 21 April 2017

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer

Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z

OncoTargets and Therapy 2017, 10:2249-2256

Published Date: 21 April 2017

PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro

Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X

OncoTargets and Therapy 2017, 10:2239-2247

Published Date: 20 April 2017

Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer

Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2227-2237

Published Date: 20 April 2017

NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo

Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y

OncoTargets and Therapy 2017, 10:2219-2226

Published Date: 19 April 2017

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer

Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ

OncoTargets and Therapy 2017, 10:2209-2217

Published Date: 19 April 2017

Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients

You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z

OncoTargets and Therapy 2017, 10:2199-2208

Published Date: 18 April 2017

Novel insights into circular RNAs in clinical application of carcinomas

Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H

OncoTargets and Therapy 2017, 10:2183-2188

Published Date: 18 April 2017

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F

OncoTargets and Therapy 2017, 10:2173-2181

Published Date: 18 April 2017

Monosomal karyotype in myeloid neoplasias: a literature review

Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F

OncoTargets and Therapy 2017, 10:2163-2171

Published Date: 20 April 2017

Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection

Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D

OncoTargets and Therapy 2017, 10:2155-2162

Published Date: 13 April 2017

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy

Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2147-2154

Published Date: 12 April 2017

Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells

Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X

OncoTargets and Therapy 2017, 10:2139-2146

Published Date: 12 April 2017

miR-762 can negatively regulate menin in ovarian cancer

Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L

OncoTargets and Therapy 2017, 10:2127-2137

Published Date: 12 April 2017

A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway

Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C

OncoTargets and Therapy 2017, 10:2115-2126

Published Date: 12 April 2017

Gastric cancer, nutritional status, and outcome

Liu X, Qiu H, Kong P, Zhou Z, Sun X

OncoTargets and Therapy 2017, 10:2107-2114

Published Date: 12 April 2017

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Wagner LM, Adams VR

OncoTargets and Therapy 2017, 10:2097-2106

Published Date: 12 April 2017

Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors

Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S

OncoTargets and Therapy 2017, 10:2077-2085

Published Date: 12 April 2017

Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients

Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC

OncoTargets and Therapy 2017, 10:2069-2075

Published Date: 10 April 2017

The role of KPNβ1 in neuro-oncology

Lilley M, Farassati F

OncoTargets and Therapy 2017, 10:2067-2068

Published Date: 10 April 2017

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7

Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J

OncoTargets and Therapy 2017, 10:2045-2056

Published Date: 7 April 2017

Expression and significance of GRHL2 in esophageal cancer

Shao CC, Ji CS, Wang XQ, Hu B

OncoTargets and Therapy 2017, 10:2025-2031

Published Date: 7 April 2017

REG3A promotes the proliferation, migration, and invasion of gastric cancer cells

Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF

OncoTargets and Therapy 2017, 10:2017-2023

Published Date: 6 April 2017

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients

Chen J, Li H, Pang RL, Huang J

OncoTargets and Therapy 2017, 10:2003-2007

Published Date: 6 April 2017

Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer

Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ

OncoTargets and Therapy 2017, 10:1993-2002

Published Date: 6 April 2017

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A

OncoTargets and Therapy 2017, 10:1983-1992

Published Date: 6 April 2017

Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation

Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF

OncoTargets and Therapy 2017, 10:1977-1982

Published Date: 4 April 2017

HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population

Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC

OncoTargets and Therapy 2017, 10:1969-1975

Published Date: 4 April 2017

Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer

Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q

OncoTargets and Therapy 2017, 10:1947-1954

Published Date: 3 April 2017

Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line

Attar R, Cincin ZB, Bireller ES, Cakmakoglu B

OncoTargets and Therapy 2017, 10:1941-1946

Published Date: 31 March 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:1933-1939

Published Date: 30 March 2017

Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane

Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:1921-1932

Published Date: 30 March 2017

Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication

Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q

OncoTargets and Therapy 2017, 10:1915-1920

Published Date: 29 March 2017

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia

Khan M, Gibbons JL, Ferrajoli A

OncoTargets and Therapy 2017, 10:1909-1914

Published Date: 29 March 2017

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis

Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH

OncoTargets and Therapy 2017, 10:1897-1908

Published Date: 29 March 2017

Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis

Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A

OncoTargets and Therapy 2017, 10:1889-1896

Published Date: 29 March 2017

Genetic variants and increased risk of meningioma: an updated meta-analysis

Han X, Wang W, Wang L, Wang X, Li G

OncoTargets and Therapy 2017, 10:1875-1888

Published Date: 28 March 2017

DNMT1 regulates human endometrial carcinoma cell proliferation

Wang X, Li B

OncoTargets and Therapy 2017, 10:1865-1873

Published Date: 29 March 2017

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K

OncoTargets and Therapy 2017, 10:1859-1863

Published Date: 28 March 2017

Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature

Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z

OncoTargets and Therapy 2017, 10:1853-1858

Published Date: 27 March 2017

Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis

Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L

OncoTargets and Therapy 2017, 10:1843-1852

Published Date: 27 March 2017

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial

Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G

OncoTargets and Therapy 2017, 10:1835-1842

Published Date: 24 March 2017

Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression

Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y

OncoTargets and Therapy 2017, 10:1827-1834

Published Date: 23 March 2017

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Song Z, Yu X, Lou G, Shi X, Zhang Y

OncoTargets and Therapy 2017, 10:1821-1825

Published Date: 23 March 2017

Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy

Robainas M, Otano R, Bueno S, Ait-Oudhia S

OncoTargets and Therapy 2017, 10:1803-1807

Published Date: 23 March 2017

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J

OncoTargets and Therapy 2017, 10:1793-1801

Published Date: 23 March 2017

Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis

Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J

OncoTargets and Therapy 2017, 10:1777-1781

Published Date: 23 March 2017

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G

OncoTargets and Therapy 2017, 10:1767-1776

Published Date: 23 March 2017

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W

OncoTargets and Therapy 2017, 10:1743-1755

Published Date: 22 March 2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

OncoTargets and Therapy 2017, 10:1735-1742

Published Date: 21 March 2017

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:1709-1710

Published Date: 21 March 2017

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]

Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC

OncoTargets and Therapy 2017, 10:1707-1708

Published Date: 21 March 2017

Primary pancreatic lymphoma: two case reports and a literature review

Yu L, Chen Y, Xing L

OncoTargets and Therapy 2017, 10:1687-1694

Published Date: 20 March 2017

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma

Ning X, Deng Y

OncoTargets and Therapy 2017, 10:1673-1686

Published Date: 20 March 2017

Role of cytokines and chemokines in alcohol-induced tumor promotion

Chen D, Zhang F, Ren H, Luo J, Wang S

OncoTargets and Therapy 2017, 10:1665-1671

Published Date: 17 March 2017

CDKL1 promotes tumor proliferation and invasion in colorectal cancer

Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J

OncoTargets and Therapy 2017, 10:1613-1624

Published Date: 16 March 2017

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling

Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L

OncoTargets and Therapy 2017, 10:1603-1611

Published Date: 14 March 2017

SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis

Zhang X, Fan Y, Li Z

OncoTargets and Therapy 2017, 10:1575-1583

Published Date: 14 March 2017

Mechanism of immune evasion in breast cancer

Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y

OncoTargets and Therapy 2017, 10:1561-1573

Published Date: 14 March 2017

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study

Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J

OncoTargets and Therapy 2017, 10:1535-1548

Published Date: 13 March 2017

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma

Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK

OncoTargets and Therapy 2017, 10:1527-1533

Published Date: 13 March 2017

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report

Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J

OncoTargets and Therapy 2017, 10:1521-1525

Published Date: 13 March 2017

MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]

Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J

OncoTargets and Therapy 2017, 10:1519-1520

Published Date: 10 March 2017

Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer

Sang Y, Bi X, Liu Y, Zhang W, Wang D

OncoTargets and Therapy 2017, 10:1513-1518

Published Date: 10 March 2017

Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells

Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z

OncoTargets and Therapy 2017, 10:1503-1512

Published Date: 9 March 2017

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM

OncoTargets and Therapy 2017, 10:1487-1502

Published Date: 9 March 2017

Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors

Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT

OncoTargets and Therapy 2017, 10:1475-1485

Published Date: 8 March 2017

Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors

Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z

OncoTargets and Therapy 2017, 10:1465-1474

Published Date: 7 March 2017

Chronological changes in lung cancer surgery in a single Japanese institution

Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H

OncoTargets and Therapy 2017, 10:1459-1464

Published Date: 6 March 2017

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer

Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM

OncoTargets and Therapy 2017, 10:1451-1457

Published Date: 6 March 2017

Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma

Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z

OncoTargets and Therapy 2017, 10:1441-1449

Published Date: 6 March 2017

GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis

Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M

OncoTargets and Therapy 2017, 10:1433-1440

Published Date: 6 March 2017

MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK

Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z

OncoTargets and Therapy 2017, 10:1423-1431

Published Date: 6 March 2017

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO

OncoTargets and Therapy 2017, 10:1403-1412

Published Date: 3 March 2017

Arterial stiffness in hematologic malignancies

Mozos I, Borzak G, Caraba A, Mihaescu R

OncoTargets and Therapy 2017, 10:1381-1388

Published Date: 3 March 2017

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks

Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N

OncoTargets and Therapy 2017, 10:1375-1380

Published Date: 3 March 2017

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma

Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D

OncoTargets and Therapy 2017, 10:1363-1373

Published Date: 3 March 2017

125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy:a comparison with best supportive care

Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J

OncoTargets and Therapy 2017, 10:1345-1352

Published Date: 2 March 2017

Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?

Kong X, Kong Y

OncoTargets and Therapy 2017, 10:1335-1344

Published Date: 1 March 2017

Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients

Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X

OncoTargets and Therapy 2017, 10:1285-1294

Published Date: 28 February 2017

MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis

Cai H, Chen X, Tang Y, Deng Y

OncoTargets and Therapy 2017, 10:1269-1278

Published Date: 28 February 2017

Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo

Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q

OncoTargets and Therapy 2017, 10:1261-1267

Published Date: 28 February 2017

miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma

Luan WK, Qian Y, Ni X, Bu XF, Xia Y, Wang JL, Ruan HR, Ma SJ, Xu B

OncoTargets and Therapy 2017, 10:1237-1246

Published Date: 27 February 2017

Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women

Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1207-1216

Published Date: 24 February 2017

Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort

Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X

OncoTargets and Therapy 2017, 10:1199-1206

Published Date: 24 February 2017

Aberrant histone modification in CD19+ B cells of the patients with chronic lymphocytic leukemia

Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y

OncoTargets and Therapy 2017, 10:1173-1179

Published Date: 23 February 2017

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T

OncoTargets and Therapy 2017, 10:1155-1164

Published Date: 23 February 2017

Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population

Fu W, Zhuo Z, Jia W, Zhu J, Zhu S, Lin Z, Wang F, Xia H, He J, Liu G

OncoTargets and Therapy 2017, 10:1149-1154

Published Date: 23 February 2017

Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T

OncoTargets and Therapy 2017, 10:1143-1147

Published Date: 23 February 2017

Intrahepatic cholangiocarcinoma: current perspectives

Buettner S, van Vugt JLA, IJzermans JNM, Groot Koerkamp B

OncoTargets and Therapy 2017, 10:1131-1142

Published Date: 22 February 2017

Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study

Zhao YX, Liu S, Hu YB, Ge YY, Lv DM

OncoTargets and Therapy 2017, 10:1123-1129

Published Date: 22 February 2017

Internal mammary lymph node management – further direction

Vrana D, Gatek J

OncoTargets and Therapy 2017, 10:1111-1114

Published Date: 21 February 2017

Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer

Sheng J, Fang W, Liu X, Xing S, Zhan J, Ma Y, Huang Y, Zhou N, Zhao H, Zhang L

OncoTargets and Therapy 2017, 10:1101-1110

Published Date: 21 February 2017

Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells

Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang C, Zhao W

OncoTargets and Therapy 2017, 10:1091-1100

Published Date: 22 February 2017

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Guetz S, Tufman A, von Pawel J, Rittmeyer A, Borgmeier A, Ferré P, Edlich B, Huber RM

OncoTargets and Therapy 2017, 10:1081-1089

Published Date: 21 February 2017

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma

Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H

OncoTargets and Therapy 2017, 10:1039-1047

Published Date: 20 February 2017

miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1

Zheng L, Chen J, Zhou Z, He Z

OncoTargets and Therapy 2017, 10:1027-1038

Published Date: 20 February 2017

Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells

Mang YY, Li L, Ran JH, Zhang SN, Liu J, Li LB, Chen YM, Liu J, Gao Y, Ren G

OncoTargets and Therapy 2017, 10:1003-1016

Published Date: 20 February 2017

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]

Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T

OncoTargets and Therapy 2017, 10:1001-1002

Published Date: 21 February 2017

Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis

Chen T, Wang H, Yang P, He ZY

OncoTargets and Therapy 2017, 10:993-1000

Published Date: 17 February 2017

Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study

Farzaneh E, Heydari H, Shekarchi AA, Kamran A

OncoTargets and Therapy 2017, 10:985-992

Published Date: 17 February 2017

Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis

Yi SY, Zeng LJ, Kuang Y, Cao ZJ, Zheng CJ, Zhang Y, Liao M, Yang L

OncoTargets and Therapy 2017, 10:973-984

Published Date: 17 February 2017

BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study

Cohn AL, Day B, Abhyankar S, McKenna E, Riehl T, Puzanov I

OncoTargets and Therapy 2017, 10:965-971

Published Date: 17 February 2017

Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor

Zhu S, Liu G, Fu W, Hu J, Fu K, Jia W

OncoTargets and Therapy 2017, 10:955-963

Published Date: 16 February 2017

Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis

Hao Y, Fu Q, Guo Y, Ye M, Zhao H, Wang Q, Peng X, Li Q, Wang R, Xiao W

OncoTargets and Therapy 2017, 10:945-953

Published Date: 16 February 2017

The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer

Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X

OncoTargets and Therapy 2017, 10:927-933

Published Date: 16 February 2017

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis

Lan X, Li S, Gao H, Nanding A, Quan L, Yang C, Ding S, Xue Y

OncoTargets and Therapy 2017, 10:919-926

Published Date: 16 February 2017

Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy

Tan JY, Jiang L, Cheng XW, Wang CL, Chen JS, Huang XQ, Xie P, Xia DM, Wang RS, Zhang Y

OncoTargets and Therapy 2017, 10:909-918

Published Date: 15 February 2017

Carfilzomib boosted combination therapy for relapsed multiple myeloma

Steiner RE, Manasanch EE

OncoTargets and Therapy 2017, 10:895-907

Published Date: 15 February 2017

miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma

Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S

OncoTargets and Therapy 2017, 10:885-894

Published Date: 15 February 2017

Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma

Yu S, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang X

OncoTargets and Therapy 2017, 10:879-884

Published Date: 15 February 2017

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy

Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J

OncoTargets and Therapy 2017, 10:871-877

Published Date: 14 February 2017

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis

Li Z, Yin SC, Zhang L, Liu WG, Chen B, Xing H

OncoTargets and Therapy 2017, 10:859-870

Published Date: 14 February 2017

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series

Zhang H, Chen F, Wang Z, Wu S

OncoTargets and Therapy 2017, 10:837-845

Published Date: 14 February 2017

The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma

Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H

OncoTargets and Therapy 2017, 10:819-835

Published Date: 14 February 2017

AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway

Chen JJ, Wang ZJ, Yu SS

OncoTargets and Therapy 2017, 10:811-817

Published Date: 13 February 2017

RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1

Guo Y, Zhang PD, Zhang HT, Zhang P, Xu RX

OncoTargets and Therapy 2017, 10:791-801

Published Date: 13 February 2017

Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma

Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L

OncoTargets and Therapy 2017, 10:781-790

Published Date: 13 February 2017

Efficacy of eribulin in breast cancer: a short report on the emerging new data

Eslamian G, Wilson C, Young RJ

OncoTargets and Therapy 2017, 10:773-779

Published Date: 13 February 2017

Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma

Zhang W, Pang Q, Yan C, Wang Q, Yang J, Yu S, Liu X, Yuan Z, Wang P, Xiao Z

OncoTargets and Therapy 2017, 10:763-771

Published Date: 13 February 2017

MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1

Wang J, Tang W, Liao M, Liu Y, Ai X

OncoTargets and Therapy 2017, 10:753-761

Published Date: 10 February 2017

Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia

Kohailan M, Alanazi M, Rouabhia M, Al Amri A, Parine NR, Semlali A

OncoTargets and Therapy 2017, 10:745-752

Published Date: 9 February 2017

Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma

Xu WZ, Li F, Xu ZK, Chen X, Sun B, Cao JW, Liu YG

OncoTargets and Therapy 2017, 10:725-733

Published Date: 8 February 2017

β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma

Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD

OncoTargets and Therapy 2017, 10:711-724

Published Date: 20 February 2017

Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population

Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H

OncoTargets and Therapy 2017, 10:703-709

Published Date: 8 February 2017

ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines

Li JP, Liu Y, Yin YH

OncoTargets and Therapy 2017, 10:691-701

Published Date: 7 February 2017

miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1

Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG

OncoTargets and Therapy 2017, 10:667-679

Published Date: 7 February 2017

Prognostic implications of Kindlin proteins in human osteosarcoma

Ning K, Zhang H, Wang Z, Li K

OncoTargets and Therapy 2017, 10:657-665

Published Date: 7 February 2017

Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia

Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S

OncoTargets and Therapy 2017, 10:645-656

Published Date: 7 February 2017

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway

Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T

OncoTargets and Therapy 2017, 10:627-643

Published Date: 3 February 2017

FLT3 inhibitors: clinical potential in acute myeloid leukemia

Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J

OncoTargets and Therapy 2017, 10:607-615

Published Date: 3 February 2017

Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase

Alakel N, Middeke JM, Schetelig J, Bornhäuser M

OncoTargets and Therapy 2017, 10:597-605

Published Date: 2 February 2017

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K

OncoTargets and Therapy 2017, 10:591-596

Published Date: 2 February 2017

Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents

Yang HL, Song EL, Shen GR, Zhu TH, Jiang TW, Shen H, Niu LP, Wang B, Lu ZY, Qian JP

OncoTargets and Therapy 2017, 10:579-590

Published Date: 2 February 2017

Exploring targeted therapy of osteosarcoma using proteomics data

Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D

OncoTargets and Therapy 2017, 10:565-577

Published Date: 1 February 2017

Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung

Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A

OncoTargets and Therapy 2017, 10:559-564

Published Date: 31 January 2017

Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life

Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G

OncoTargets and Therapy 2017, 10:551-557

Published Date: 27 January 2017

miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer

Yang F, Li Y, Xu L, Zhu Y, Gao H, Zhen L, Fang L

OncoTargets and Therapy 2017, 10:543-550

Published Date: 27 January 2017

Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer

Shao Q, Liu S, Wang W, zhang Y, Li F, Li J

OncoTargets and Therapy 2017, 10:535-541

Published Date: 31 January 2017

The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma

Zhong GX, Feng SD, Shen RK, Wu Z, Chen F, Zhu X

OncoTargets and Therapy 2017, 10:527-533

Published Date: 8 February 2017

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease

Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M

OncoTargets and Therapy 2017, 10:521-526

Published Date: 24 January 2017

Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma

Wahid M, Jawed A, Dar SA, Mandal RK, Haque S

OncoTargets and Therapy 2017, 10:515-520

Published Date: 24 January 2017

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF

OncoTargets and Therapy 2017, 10:503-514

Published Date: 23 January 2017

Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis

Wang J, Yu M, Guan S, Zhang G, Wang J, Cheng Y

OncoTargets and Therapy 2017, 10:493-502

Published Date: 23 January 2017

Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis

Shen SD, Zhong SZ, Xiao GF, Zhou HB, Huang WH

OncoTargets and Therapy 2017, 10:477-481

Published Date: 21 January 2017

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K

OncoTargets and Therapy 2017, 10:463-476

Published Date: 21 January 2017

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis

Liu W, Wang X, Sun J, Yang Y, Li W, Song J

OncoTargets and Therapy 2017, 10:453-461

Published Date: 23 January 2017

Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma

Fang S, Zhang H, Zhang Y, Xie W

OncoTargets and Therapy 2017, 10:447-452

Published Date: 18 January 2017

Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel

Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z

OncoTargets and Therapy 2017, 10:439-446

Published Date: 18 January 2017

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status

Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K

OncoTargets and Therapy 2017, 10:429-437

Published Date: 18 January 2017

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis

Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX

OncoTargets and Therapy 2017, 10:417-428

Published Date: 18 January 2017

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF

OncoTargets and Therapy 2017, 10:409-415

Published Date: 18 January 2017

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature

Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC

OncoTargets and Therapy 2017, 10:397-407

Published Date: 18 January 2017

FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma

Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L

OncoTargets and Therapy 2017, 10:387-395

Published Date: 16 January 2017

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J

OncoTargets and Therapy 2017, 10:371-385

Published Date: 16 January 2017

Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma

Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y

OncoTargets and Therapy 2017, 10:363-370

Published Date: 13 January 2017

Advances in antiangiogenic treatment of small-cell lung cancer

Lu H, Jiang Z

OncoTargets and Therapy 2017, 10:353-359

Published Date: 12 January 2017

Chidamide in the treatment of peripheral T-cell lymphoma

Chan TS, Tse E, Kwong YL

OncoTargets and Therapy 2017, 10:347-352

Published Date: 12 January 2017

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy

Chen J, Liu L, Xu J

OncoTargets and Therapy 2017, 10:339-345

Published Date: 11 January 2017

Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice

Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D

OncoTargets and Therapy 2017, 10:329-338

Published Date: 11 January 2017

Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM

OncoTargets and Therapy 2017, 10:319-327

Published Date: 10 January 2017

Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor

Sun F, Li W, Wang L, Jiao C

OncoTargets and Therapy 2017, 10:311-317

Published Date: 10 January 2017

Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis

Jiang S, Xu J, Zhuo Z, Hua Z

OncoTargets and Therapy 2017, 10:303-310

Published Date: 10 January 2017

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z

OncoTargets and Therapy 2017, 10:295-302

Published Date: 10 January 2017

Correlation of SASH1 expression and ultrasonographic features in breast cancer

Gong X, Wu J, Wu J, Liu J, Gu H, Shen H

OncoTargets and Therapy 2017, 10:271-276

Published Date: 10 January 2017

Strategies of temozolomide in future glioblastoma treatment

Lee CY

OncoTargets and Therapy 2017, 10:265-270

Published Date: 9 January 2017

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY

OncoTargets and Therapy 2017, 10:247-257

Published Date: 9 January 2017

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H

OncoTargets and Therapy 2017, 10:239-245

Published Date: 6 January 2017

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G

OncoTargets and Therapy 2017, 10:217-226

Published Date: 6 January 2017

Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer

Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H

OncoTargets and Therapy 2017, 10:205-216

Published Date: 5 January 2017

Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas

He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H

OncoTargets and Therapy 2017, 10:195-203

Published Date: 4 January 2017

The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer

Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ

OncoTargets and Therapy 2017, 10:185-194

Published Date: 29 December 2016

Pediatric papillary thyroid cancer: current management challenges

Verburg FA, Van Santen HM, Luster M

OncoTargets and Therapy 2017, 10:165-175

Published Date: 28 December 2016

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

OncoTargets and Therapy 2017, 10:153-163

Published Date: 28 December 2016

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma

Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X

OncoTargets and Therapy 2017, 10:145-151

Published Date: 22 December 2016

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

OncoTargets and Therapy 2017, 10:137-144

Published Date: 22 December 2016

High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma

Yan H, Tian R, Zhang M, Wu J, Ding M, He J

OncoTargets and Therapy 2017, 10:113-120

Published Date: 21 December 2016

Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study

Wang Y, Meng F, Liu Y, Chen X

OncoTargets and Therapy 2017, 10:95-100

Published Date: 20 December 2016

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:85-94

Published Date: 20 December 2016

RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src

Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y

OncoTargets and Therapy 2017, 10:73-83

Published Date: 5 January 2017

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL

OncoTargets and Therapy 2017, 10:67-72

Published Date: 20 December 2016

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma

Cheng Y, Xing SG, Jia WD, Huang M, Bian NN

OncoTargets and Therapy 2017, 10:47-54

Published Date: 19 December 2016

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP

Lei R, Xue M, Zhang L, Lin ZQ

OncoTargets and Therapy 2017, 10:35-46

Published Date: 19 December 2016

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report

Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M

OncoTargets and Therapy 2017, 10:31-34

Published Date: 19 December 2016

Potential role of immunotherapy in advanced non-small-cell lung cancer

de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G

OncoTargets and Therapy 2017, 10:21-30

Published Date: 16 December 2016

J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)

Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K

OncoTargets and Therapy 2017, 10:13-19

Published Date: 16 December 2016

Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients

Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1-11

Published Date: 16 December 2016

Non-secretory multiple myeloma: from biology to clinical management

Dupuis MM, Tuchman SA

OncoTargets and Therapy 2016, 9:7583-7590

Published Date: 15 December 2016

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

Mulet-Margalef N, Garcia-del-Muro X

OncoTargets and Therapy 2016, 9:7573-7582

Published Date: 15 December 2016

Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner

Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L

OncoTargets and Therapy 2016, 9:7563-7571

Published Date: 14 December 2016

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role

Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E

OncoTargets and Therapy 2016, 9:7545-7553

Published Date: 13 December 2016

The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning

Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R

OncoTargets and Therapy 2016, 9:7537-7544

Published Date: 12 December 2016

A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD

OncoTargets and Therapy 2016, 9:7527-7535

Published Date: 12 December 2016

β-Elemene treatment of glioblastoma: a single-center retrospective study

Ma C, Zhou W, Yan Z, Qu M, Bu X

OncoTargets and Therapy 2016, 9:7521-7526

Published Date: 12 December 2016

Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells

Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF

OncoTargets and Therapy 2016, 9:7503-7513

Published Date: 13 December 2016

Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma

Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S

OncoTargets and Therapy 2016, 9:7493-7501

Published Date: 12 December 2016

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells

Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M

OncoTargets and Therapy 2016, 9:7481-7492

Published Date: 12 December 2016

Biomarkers in pancreatic adenocarcinoma: current perspectives

Swords DS, Firpo MA, Scaife CL, Mulvihill SJ

OncoTargets and Therapy 2016, 9:7459-7467

Published Date: 9 December 2016

Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements

Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H

OncoTargets and Therapy 2016, 9:7445-7450

Published Date: 9 December 2016

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population

Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X

OncoTargets and Therapy 2016, 9:7415-7424

Published Date: 8 December 2016

Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis

Shi H, Wang X, Wang J, Pan J, Liu J, Ye B

OncoTargets and Therapy 2016, 9:7409-7414

Published Date: 8 December 2016

Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data

Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y

OncoTargets and Therapy 2016, 9:7397-7407

Published Date: 7 December 2016

Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran

Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S

OncoTargets and Therapy 2016, 9:7385-7395

Published Date: 7 December 2016

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway

Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G

OncoTargets and Therapy 2016, 9:7373-7384

Published Date: 5 December 2016

Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma

Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z

OncoTargets and Therapy 2016, 9:7367-7372

Published Date: 2 December 2016

Next-generation sequencing: advances and applications in cancer diagnosis

Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R

OncoTargets and Therapy 2016, 9:7355-7365

Published Date: 2 December 2016

Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches

Lakhlili W, Yasri A, Ibrahimi A

OncoTargets and Therapy 2016, 9:7345-7353

Published Date: 2 December 2016

History and progression of Fat cadherins in health and disease

Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X

OncoTargets and Therapy 2016, 9:7337-7343

Published Date: 1 December 2016

Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel

Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M

OncoTargets and Therapy 2016, 9:7315-7330

Published Date: 1 December 2016

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC

OncoTargets and Therapy 2016, 9:7309-7314

Published Date: 30 November 2016

Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1

Zhang J, Fu J, Pan Y, Zhang X, Shen L

OncoTargets and Therapy 2016, 9:7297-7307

Published Date: 1 December 2016

CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer

Yang K, Gao K, Hu G, Wen Y, Lin C, Li X

OncoTargets and Therapy 2016, 9:7285-7295

Published Date: 30 November 2016

Androgen deprivation therapy as backbone therapy in the management of prostate cancer

Merseburger AS, Alcaraz A, von Klot CA

OncoTargets and Therapy 2016, 9:7263-7274

Published Date: 29 November 2016

Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression

Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY

OncoTargets and Therapy 2016, 9:7253-7261

Published Date: 28 November 2016

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives

Davidson M, Starling N

OncoTargets and Therapy 2016, 9:7235-7245

Published Date: 25 November 2016

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol

Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY

OncoTargets and Therapy 2016, 9:7219-7225

Published Date: 22 November 2016

Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time

Baek N, Seo OW, Kim M, Hulme J, An SSA

OncoTargets and Therapy 2016, 9:7207-7218

Published Date: 22 November 2016

High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma

Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J

OncoTargets and Therapy 2016, 9:7199-7205

Published Date: 22 November 2016

Effect of smoking on the genetic makeup of toll-like receptors 2 and 6

Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A

OncoTargets and Therapy 2016, 9:7187-7198

Published Date: 21 November 2016

The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma

Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H

OncoTargets and Therapy 2016, 9:7177-7185

Published Date: 21 November 2016

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity

Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H

OncoTargets and Therapy 2016, 9:7169-7175

Published Date: 18 November 2016

Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma

Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC

OncoTargets and Therapy 2016, 9:7161-7167

Published Date: 18 November 2016

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK

OncoTargets and Therapy 2016, 9:7149-7159

Published Date: 12 December 2016

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus

Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S

OncoTargets and Therapy 2016, 9:7141-7147

Published Date: 1 December 2016

Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells

Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W

OncoTargets and Therapy 2016, 9:7115-7122

Published Date: 17 November 2016

Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases

Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G

OncoTargets and Therapy 2016, 9:7105-7114

Published Date: 17 November 2016

Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial

Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL

OncoTargets and Therapy 2016, 9:7081-7093

Published Date: 16 November 2016

Lrig1 is a positive prognostic marker in hepatocellular carcinoma

Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS

OncoTargets and Therapy 2016, 9:7071-7079

Published Date: 15 November 2016

MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1

Xu D, Chen XF, He QY, Luo CQ

OncoTargets and Therapy 2016, 9:7047-7057

Published Date: 15 November 2016

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer

Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O

OncoTargets and Therapy 2016, 9:7039-7045

Published Date: 15 November 2016

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma

Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ

OncoTargets and Therapy 2016, 9:7019-7028

Published Date: 14 November 2016

CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma

Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF

OncoTargets and Therapy 2016, 9:7011-7017

Published Date: 14 November 2016

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1

Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S

OncoTargets and Therapy 2016, 9:6999-7009

Published Date: 14 November 2016

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis

Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ

OncoTargets and Therapy 2016, 9:6987-6998

Published Date: 24 November 2016

Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis

Yang X, Yang L, Dai W, Ye B

OncoTargets and Therapy 2016, 9:6977-6985

Published Date: 11 November 2016

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis

Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L

OncoTargets and Therapy 2016, 9:6965-6976

Published Date: 11 November 2016

Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer

Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D

OncoTargets and Therapy 2016, 9:6945-6951

Published Date: 17 November 2016

Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion

Chen B, Xia L, Xu C, Xiao F, Wang Y

OncoTargets and Therapy 2016, 9:6935-6943

Published Date: 9 November 2016

Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells

Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:6921-6933

Published Date: 11 November 2016

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma

Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L

OncoTargets and Therapy 2016, 9:6915-6920

Published Date: 8 November 2016

miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition

Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM

OncoTargets and Therapy 2016, 9:6909-6914

Published Date: 8 November 2016

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ

OncoTargets and Therapy 2016, 9:6897-6907

Published Date: 10 November 2016

Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer

Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ

OncoTargets and Therapy 2016, 9:6885-6895

Published Date: 7 November 2016

Hürthle cell carcinoma: current perspectives

Ahmadi S, Stang M, Jiang XS, Sosa JA

OncoTargets and Therapy 2016, 9:6873-6884

Published Date: 7 November 2016

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells

Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q

OncoTargets and Therapy 2016, 9:6865-6871

Published Date: 7 November 2016

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma

El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM

OncoTargets and Therapy 2016, 9:6857-6863

Published Date: 7 November 2016

Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma

Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A

OncoTargets and Therapy 2016, 9:6843-6855

Published Date: 9 November 2016

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma

Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S

OncoTargets and Therapy 2016, 9:6835-6841

Published Date: 4 November 2016

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management

Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G

OncoTargets and Therapy 2016, 9:6829-6834

Published Date: 4 November 2016

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening

Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E

OncoTargets and Therapy 2016, 9:6819-6828

Published Date: 4 November 2016

Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography

Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX

OncoTargets and Therapy 2016, 9:6809-6817

Published Date: 3 November 2016

Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis

Yang Y, Xiong Y, Li J, Wu C, Jiang J

OncoTargets and Therapy 2016, 9:6801-6808

Published Date: 3 November 2016

Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials

Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y

OncoTargets and Therapy 2016, 9:6795-6800

Published Date: 7 November 2016

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking

Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N

OncoTargets and Therapy 2016, 9:6785-6794

Published Date: 2 November 2016

Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study

Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J

OncoTargets and Therapy 2016, 9:6775-6783

Published Date: 1 November 2016

Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis

Lv L, Hu WD, Ren YC, Wei XX

OncoTargets and Therapy 2016, 9:6751-6762

Published Date: 31 October 2016

Positive expression of KIF20A indicates poor prognosis of glioma patients

Duan J, Huang W, Shi H

OncoTargets and Therapy 2016, 9:6741-6749

Published Date: 2 November 2016

A current perspective on stereotactic body radiation therapy for pancreatic cancer

Hong JC, Czito BG, Willett CG, Palta M

OncoTargets and Therapy 2016, 9:6733-6739

Published Date: 31 October 2016

Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells

Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS

OncoTargets and Therapy 2016, 9:6727-6732

Published Date: 31 October 2016

High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma

Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ

OncoTargets and Therapy 2016, 9:6719-6726

Published Date: 31 October 2016

Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer

Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y

OncoTargets and Therapy 2016, 9:6711-6718

Published Date: 31 October 2016

Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis

Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X

OncoTargets and Therapy 2016, 9:6701-6710

Published Date: 28 October 2016

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H

OncoTargets and Therapy 2016, 9:6689-6693

Published Date: 28 October 2016

Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression

Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H

OncoTargets and Therapy 2016, 9:6679-6687

Published Date: 28 October 2016

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A

OncoTargets and Therapy 2016, 9:6669-6677

Published Date: 4 November 2016

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N

OncoTargets and Therapy 2016, 9:6663-6668

Published Date: 27 October 2016

The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells

Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ

OncoTargets and Therapy 2016, 9:6651-6661

Published Date: 27 October 2016

Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects

Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y

OncoTargets and Therapy 2016, 9:6641-6650

Published Date: 27 October 2016

MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin

Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X

OncoTargets and Therapy 2016, 9:6631-6640

Published Date: 28 October 2016

BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer

Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL

OncoTargets and Therapy 2016, 9:6619-6629

Published Date: 26 October 2016

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis

Ye CY, Wang J, Zheng S, Chai Y

OncoTargets and Therapy 2016, 9:6605-6608

Published Date: 26 October 2016

The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer

Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D

OncoTargets and Therapy 2016, 9:6581-6595

Published Date: 25 October 2016

Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease

Hua J, Ding T, Yang L

OncoTargets and Therapy 2016, 9:6573-6579

Published Date: 25 October 2016

Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study

Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y

OncoTargets and Therapy 2016, 9:6569-6572

Published Date: 25 October 2016

Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia

Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA

OncoTargets and Therapy 2016, 9:6561-6567

Published Date: 25 October 2016

Cell-free DNA as a diagnostic marker for cancer: current insights

Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V

OncoTargets and Therapy 2016, 9:6549-6559

Published Date: 25 October 2016

Novel therapeutic strategies for patients with triple-negative breast cancer

Zhang JF, Liu J, Wang Y, Zhang B

OncoTargets and Therapy 2016, 9:6519-6528

Published Date: 21 October 2016

Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines

Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M

OncoTargets and Therapy 2016, 9:6485-6498

Published Date: 20 October 2016

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China

Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B

OncoTargets and Therapy 2016, 9:6479-6484

Published Date: 20 October 2016

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R

OncoTargets and Therapy 2016, 9:6467-6477

Published Date: 20 October 2016

Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis

Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T

OncoTargets and Therapy 2016, 9:6461-6466

Published Date: 19 October 2016

Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database

Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY

OncoTargets and Therapy 2016, 9:6435-6444

Published Date: 19 October 2016

Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma

Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM

OncoTargets and Therapy 2016, 9:6425-6433

Published Date: 19 October 2016

Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma

He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q

OncoTargets and Therapy 2016, 9:6399-6406

Published Date: 18 October 2016

Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma

Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:6389-6397

Published Date: 17 October 2016

Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus

Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X

OncoTargets and Therapy 2016, 9:6381-6388

Published Date: 17 October 2016

miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]

Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L

OncoTargets and Therapy 2016, 9:6379-6380

Published Date: 20 October 2016

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]

Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY

OncoTargets and Therapy 2016, 9:6377-6378

Published Date: 20 October 2016

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F

OncoTargets and Therapy 2016, 9:6361-6376

Published Date: 17 October 2016

Cancer: fundamentals behind pH targeting and the double-edged approach

Koltai T

OncoTargets and Therapy 2016, 9:6343-6360

Published Date: 17 October 2016

Rare frequency of gene variation and survival analysis in thymic epithelial tumors

Song Z, Yu X, Zhang Y

OncoTargets and Therapy 2016, 9:6337-6342

Published Date: 14 October 2016

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A

OncoTargets and Therapy 2016, 9:6325-6332

Published Date: 14 October 2016

18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients

Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY

OncoTargets and Therapy 2016, 9:6315-6324

Published Date: 14 October 2016

Prognostic value of endocan expression in cancers: evidence from meta-analysis

Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L

OncoTargets and Therapy 2016, 9:6297-6304

Published Date: 13 October 2016

Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review

Qi D, Feng L, Li J, Liu B, Zhang Q

OncoTargets and Therapy 2016, 9:6291-6296

Published Date: 13 October 2016

Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation

Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR

OncoTargets and Therapy 2016, 9:6281-6290

Published Date: 13 October 2016

CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma

Yang T, Huang Y, Jing X, Gai X, Li W

OncoTargets and Therapy 2016, 9:6273-6279

Published Date: 13 October 2016

Locally advanced rectal cancer: management challenges

Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J

OncoTargets and Therapy 2016, 9:6265-6272

Published Date: 13 October 2016

Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis

Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S

OncoTargets and Therapy 2016, 9:6257-6263

Published Date: 12 October 2016

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T

OncoTargets and Therapy 2016, 9:6233-6246

Published Date: 11 October 2016

Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma

Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L

OncoTargets and Therapy 2016, 9:6225-6231

Published Date: 11 October 2016

Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis

Yu H, Li H, Zhang J, Liu G

OncoTargets and Therapy 2016, 9:6211-6224

Published Date: 11 October 2016

miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer

He S, Zhang G, Dong H, Ma M, Sun Q

OncoTargets and Therapy 2016, 9:6203-6210

Published Date: 11 October 2016

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ

OncoTargets and Therapy 2016, 9:6195-6201

Published Date: 11 October 2016

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma

Zhu S, Miao CW, Wang ZT, Peng L, Li B

OncoTargets and Therapy 2016, 9:6187-6193

Published Date: 13 October 2016

Invasive atypical thymic carcinoid: three case reports and literature review

Zhu S, Wang Z, Liu W, Zong S, Li B

OncoTargets and Therapy 2016, 9:6171-6176

Published Date: 11 October 2016

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN

OncoTargets and Therapy 2016, 9:6151-6160

Published Date: 11 October 2016

Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma

Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N

OncoTargets and Therapy 2016, 9:6147-6150

Published Date: 11 October 2016

Prognostic value of microRNA-126 and CRK expression in gastric cancer

Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D

OncoTargets and Therapy 2016, 9:6127-6135

Published Date: 11 October 2016

Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas

Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L

OncoTargets and Therapy 2016, 9:6111-6117

Published Date: 11 October 2016

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer

He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS

OncoTargets and Therapy 2016, 9:6099-6109

Published Date: 7 October 2016

Primary breast diffuse large B-cell lymphoma in the era of rituximab

Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N

OncoTargets and Therapy 2016, 9:6093-6097

Published Date: 7 October 2016

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y

OncoTargets and Therapy 2016, 9:6075-6082

Published Date: 6 October 2016

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E

OncoTargets and Therapy 2016, 9:6065-6074

Published Date: 6 October 2016

Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis

Yu D, Cao T, Han YD, Huang FS

OncoTargets and Therapy 2016, 9:6049-6057

Published Date: 5 October 2016

miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway

Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J

OncoTargets and Therapy 2016, 9:6009-6019

Published Date: 3 October 2016

Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer

Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X

OncoTargets and Therapy 2016, 9:5999-6008

Published Date: 3 October 2016

CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma

Li L, Li Y, Zhao J, Fan S, Wang L, Li X

OncoTargets and Therapy 2016, 9:5985-5997

Published Date: 29 September 2016

Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study

Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L

OncoTargets and Therapy 2016, 9:5975-5983

Published Date: 29 September 2016

Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma

Fu H, Qi L, Chen L, He Y, Zhang N, Guo H

OncoTargets and Therapy 2016, 9:5963-5973

Published Date: 29 September 2016

Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma

Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ

OncoTargets and Therapy 2016, 9:5955-5961

Published Date: 28 September 2016

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

Abedin SM, Boddy CS, Munshi HG

OncoTargets and Therapy 2016, 9:5943-5953

Published Date: 28 September 2016

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III

OncoTargets and Therapy 2016, 9:5931-5941

Published Date: 29 September 2016

The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY

OncoTargets and Therapy 2016, 9:5919-5929

Published Date: 27 September 2016

Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study

Jalili A, Irani S, Mirfakhraie R

OncoTargets and Therapy 2016, 9:5911-5917

Published Date: 28 September 2016

Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma

Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P

OncoTargets and Therapy 2016, 9:5903-5909

Published Date: 26 September 2016

Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study

Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY

OncoTargets and Therapy 2016, 9:5897-5902

Published Date: 26 September 2016

Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification

Ren T, Lin SD, Wang ZF, Shang AJ

OncoTargets and Therapy 2016, 9:5883-5895

Published Date: 27 September 2016

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy

Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ

OncoTargets and Therapy 2016, 9:5875-5881

Published Date: 26 September 2016

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L

OncoTargets and Therapy 2016, 9:5867-5874

Published Date: 23 September 2016

Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date

Vachhani P, Chen H

OncoTargets and Therapy 2016, 9:5855-5866

Published Date: 23 September 2016

Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals

Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R

OncoTargets and Therapy 2016, 9:5847-5854

Published Date: 23 September 2016

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K

OncoTargets and Therapy 2016, 9:5839-5845

Published Date: 23 September 2016

An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter

Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M

OncoTargets and Therapy 2016, 9:5819-5823

Published Date: 22 September 2016

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors

Yıldız Y, Sokmensuer C, Yalcin S

OncoTargets and Therapy 2016, 9:5809-5817

Published Date: 22 September 2016

Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer

Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J

OncoTargets and Therapy 2016, 9:5803-5808

Published Date: 22 September 2016

A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature

Zhang C, Zhang W, Mu D, Shi X, Zhao L

OncoTargets and Therapy 2016, 9:5797-5802

Published Date: 22 September 2016

Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis

Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q

OncoTargets and Therapy 2016, 9:5771-5779

Published Date: 21 September 2016

Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer

Wang X, Teng F, Kong L, Yu J

OncoTargets and Therapy 2016, 9:5761-5770

Published Date: 20 September 2016

The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients

Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D

OncoTargets and Therapy 2016, 9:5751-5759

Published Date: 19 September 2016

The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer

Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J

OncoTargets and Therapy 2016, 9:5737-5750

Published Date: 26 September 2016

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK

OncoTargets and Therapy 2016, 9:5729-5736

Published Date: 19 September 2016

Proton beam therapy: clinical utility and current status in prostate cancer

Yamoah K, Johnstone PA

OncoTargets and Therapy 2016, 9:5721-5727

Published Date: 16 September 2016

A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer

Zhai N, Xia Y, Yin R, Liu J, Gao F

OncoTargets and Therapy 2016, 9:5713-5720

Published Date: 16 September 2016

Identifying module biomarkers from gastric cancer by differential correlation network

Liu X, Chang X

OncoTargets and Therapy 2016, 9:5701-5711

Published Date: 19 September 2016

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]

Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L

OncoTargets and Therapy 2016, 9:5699-5700

Published Date: 20 September 2016

MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma

Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK

OncoTargets and Therapy 2016, 9:5679-5692

Published Date: 15 September 2016

Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma

Doan HQ, Silapunt S, Migden MR

OncoTargets and Therapy 2016, 9:5671-5678

Published Date: 14 September 2016

Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma

Tian C, Zhang Y

OncoTargets and Therapy 2016, 9:5659-5661

Published Date: 13 September 2016

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass

Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T

OncoTargets and Therapy 2016, 9:5651-5657

Published Date: 13 September 2016

The association of PTEN hypermethylation and breast cancer: a meta-analysis

Luo S, Chen J, Mo X

OncoTargets and Therapy 2016, 9:5643-5650

Published Date: 12 September 2016

Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms

Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG

OncoTargets and Therapy 2016, 9:5611-5617

Published Date: 9 September 2016

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5603-5609

Published Date: 9 September 2016

Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma

Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X

OncoTargets and Therapy 2016, 9:5597-5602

Published Date: 9 September 2016

Proton therapy for early stage prostate cancer: is there a case?

Chan TY, Tan PW, Tang JI

OncoTargets and Therapy 2016, 9:5577-5586

Published Date: 9 September 2016

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF

OncoTargets and Therapy 2016, 9:5567-5575

Published Date: 8 September 2016

Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program

Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI

OncoTargets and Therapy 2016, 9:5561-5566

Published Date: 8 September 2016

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer

Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H

OncoTargets and Therapy 2016, 9:5553-5560

Published Date: 7 September 2016

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity

Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS

OncoTargets and Therapy 2016, 9:5531-5543

Published Date: 7 September 2016

Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes

Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A

OncoTargets and Therapy 2016, 9:5521-5530

Published Date: 7 September 2016

Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population

Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH

OncoTargets and Therapy 2016, 9:5513-5519

Published Date: 7 September 2016

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report

Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A

OncoTargets and Therapy 2016, 9:5507-5511

Published Date: 7 September 2016

Sunitinib: the antiangiogenic effects and beyond

Hao Z, Sadek I

OncoTargets and Therapy 2016, 9:5495-5505

Published Date: 8 September 2016

Osimertinib making a breakthrough in lung cancer targeted therapy

Zhang H

OncoTargets and Therapy 2016, 9:5489-5493

Published Date: 6 September 2016

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B

OncoTargets and Therapy 2016, 9:5483-5488

Published Date: 6 September 2016

Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis

Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W

OncoTargets and Therapy 2016, 9:5451-5459

Published Date: 6 September 2016

Identifying candidate agents for lung adenocarcinoma by walking the human interactome

Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F

OncoTargets and Therapy 2016, 9:5439-5450

Published Date: 1 September 2016

Clinical potential of necitumumab in non-small cell lung carcinoma

Genova C, Hirsch FR

OncoTargets and Therapy 2016, 9:5427-5437

Published Date: 31 August 2016

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G

OncoTargets and Therapy 2016, 9:5399-5404

Published Date: 30 August 2016

Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer

Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T

OncoTargets and Therapy 2016, 9:5389-5397

Published Date: 6 September 2016

Pitavastatin suppressed liver cancer cells in vitro and in vivo

You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ

OncoTargets and Therapy 2016, 9:5383-5388

Published Date: 29 August 2016

Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer

Feng J, Gou J, Jia J, Yi T, Cui T, Li Z

OncoTargets and Therapy 2016, 9:5371-5381

Published Date: 29 August 2016

Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study

Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ

OncoTargets and Therapy 2016, 9:5361-5369

Published Date: 13 September 2016

ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway

Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M

OncoTargets and Therapy 2016, 9:5349-5360

Published Date: 29 August 2016

Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells

Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X

OncoTargets and Therapy 2016, 9:5329-5338

Published Date: 24 August 2016

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma

Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C

OncoTargets and Therapy 2016, 9:5317-5328

Published Date: 24 August 2016

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma

Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL

OncoTargets and Therapy 2016, 9:5307-5316

Published Date: 24 August 2016

Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells

Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T

OncoTargets and Therapy 2016, 9:5297-5305

Published Date: 24 August 2016

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T

OncoTargets and Therapy 2016, 9:5287-5295

Published Date: 24 August 2016

Expression and prognostic significance of unique ULBPs in pancreatic cancer

Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ

OncoTargets and Therapy 2016, 9:5271-5279

Published Date: 25 August 2016

Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma

Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG

OncoTargets and Therapy 2016, 9:5257-5270

Published Date: 25 August 2016

MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer

Liu D, Xia H, Wang F, Chen C, Long J

OncoTargets and Therapy 2016, 9:5245-5255

Published Date: 23 August 2016

Prognostic significance of TAZ expression in various cancers: a meta-analysis

Feng J, Ren P, Gou J, Li Z

OncoTargets and Therapy 2016, 9:5235-5244

Published Date: 23 August 2016

Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis

Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C

OncoTargets and Therapy 2016, 9:5225-5233

Published Date: 22 August 2016

Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis

Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T

OncoTargets and Therapy 2016, 9:5209-5216

Published Date: 22 August 2016

Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT

Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX

OncoTargets and Therapy 2016, 9:5195-5202

Published Date: 29 August 2016

Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study

Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW

OncoTargets and Therapy 2016, 9:5163-5180

Published Date: 22 August 2016

Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma

Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB

OncoTargets and Therapy 2016, 9:5143-5152

Published Date: 18 August 2016

Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance

Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B

OncoTargets and Therapy 2016, 9:5133-5142

Published Date: 18 August 2016

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma

Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ

OncoTargets and Therapy 2016, 9:5123-5131

Published Date: 18 August 2016

Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment

El-Osta HE, Shahid K, Mills GM, Peddi P

OncoTargets and Therapy 2016, 9:5101-5116

Published Date: 16 August 2016

MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK

Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P

OncoTargets and Therapy 2016, 9:5091-5099

Published Date: 16 August 2016

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5073-5080

Published Date: 12 August 2016

Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis

Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH

OncoTargets and Therapy 2016, 9:5061-5071

Published Date: 12 August 2016

Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells

Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X

OncoTargets and Therapy 2016, 9:5049-5059

Published Date: 12 August 2016

New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer

Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB

OncoTargets and Therapy 2016, 9:5041-5047

Published Date: 12 August 2016

PD-L1 expression in human cancers and its association with clinical outcomes

Wang X, Teng FF, Kong L, Yu JM

OncoTargets and Therapy 2016, 9:5023-5039

Published Date: 12 August 2016

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model

Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH

OncoTargets and Therapy 2016, 9:5015-5022

Published Date: 12 August 2016

Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9

Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B

OncoTargets and Therapy 2016, 9:5005-5014

Published Date: 12 August 2016

Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer

Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW

OncoTargets and Therapy 2016, 9:4993-5003

Published Date: 16 August 2016

Successful treatment of angiosarcoma of the scalp with apatinib: a case report

Ji G, Hong L, Yang P

OncoTargets and Therapy 2016, 9:4989-4992

Published Date: 11 August 2016

Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer

He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD

OncoTargets and Therapy 2016, 9:4983-4987

Published Date: 11 August 2016

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study

Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH

OncoTargets and Therapy 2016, 9:4975-4981

Published Date: 11 August 2016

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Feng L, Qi DJ, Zhang QF

OncoTargets and Therapy 2016, 9:4969-4974

Published Date: 10 August 2016

Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases

Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK

OncoTargets and Therapy 2016, 9:4959-4968

Published Date: 10 August 2016

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS

OncoTargets and Therapy 2016, 9:4937-4957

Published Date: 10 August 2016

Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting

Seber S, Solmaz D, Yetisyigit T

OncoTargets and Therapy 2016, 9:4929-4935

Published Date: 9 August 2016

A rare case report of primary bone lymphoma and a brief review of the literature

Wang J, Fan S, Liu J, Song B,

OncoTargets and Therapy 2016, 9:4923-4928

Published Date: 9 August 2016

Incidental gallbladder cancer after cholecystectomy: 1990 to 2014

Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D

OncoTargets and Therapy 2016, 9:4913-4916

Published Date: 8 August 2016

High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway

Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY

OncoTargets and Therapy 2016, 9:4887-4899

Published Date: 8 August 2016

A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y

OncoTargets and Therapy 2016, 9:4879-4886

Published Date: 8 August 2016

Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells

Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE

OncoTargets and Therapy 2016, 9:4867-4878

Published Date: 8 August 2016

Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?

Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T

OncoTargets and Therapy 2016, 9:4843-4858

Published Date: 5 August 2016

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis

Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q

OncoTargets and Therapy 2016, 9:4821-4831

Published Date: 3 August 2016

A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer

Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S

OncoTargets and Therapy 2016, 9:4815-4820

Published Date: 3 August 2016

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients

Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M

OncoTargets and Therapy 2016, 9:4805-4813

Published Date: 2 August 2016

Cutaneous basal cell carcinoma arising within a keloid scar: a case report

Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A

OncoTargets and Therapy 2016, 9:4793-4796

Published Date: 2 August 2016

Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer

Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ

OncoTargets and Therapy 2016, 9:4785-4791

Published Date: 2 August 2016

Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma

Chen YJ, Chen CC, Huang HL

OncoTargets and Therapy 2016, 9:4773-4783

Published Date: 1 August 2016

Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells

Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD

OncoTargets and Therapy 2016, 9:4763-4771

Published Date: 1 August 2016

Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition

Zhang X, Wang P, Zhao L, Yuan Z, Wang P

OncoTargets and Therapy 2016, 9:4757-4762

Published Date: 29 July 2016

Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study

Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y

OncoTargets and Therapy 2016, 9:4747-4751

Published Date: 29 July 2016

RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines

Moela P, Motadi LR

OncoTargets and Therapy 2016, 9:4721-4735

Published Date: 29 July 2016

Primary yolk sac tumor of the gluteus: a case report and literature review

Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L

OncoTargets and Therapy 2016, 9:4715-4719

Published Date: 2 August 2016

MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4

Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J

OncoTargets and Therapy 2016, 9:4705-4714

Published Date: 29 July 2016

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy

Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M

OncoTargets and Therapy 2016, 9:4695-4703

Published Date: 28 July 2016

The impact of the extent of surgical resection on survival of gastric cancer patients

Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT

OncoTargets and Therapy 2016, 9:4687-4694

Published Date: 28 July 2016

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N

OncoTargets and Therapy 2016, 9:4681-4686

Published Date: 28 July 2016

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer

Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK

OncoTargets and Therapy 2016, 9:4653-4660

Published Date: 27 July 2016

Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients

Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD

OncoTargets and Therapy 2016, 9:4645-4652

Published Date: 26 July 2016

MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2

Xu L, Shen B, Chen TT, Dong P

OncoTargets and Therapy 2016, 9:4629-4637

Published Date: 26 July 2016

Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells

Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H

OncoTargets and Therapy 2016, 9:4605-4616

Published Date: 25 July 2016

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B

OncoTargets and Therapy 2016, 9:4583-4591

Published Date: 25 July 2016

Network analysis reveals potential markers for pediatric adrenocortical carcinoma

Kulshrestha A, Suman S, Ranjan R

OncoTargets and Therapy 2016, 9:4569-4581

Published Date: 26 July 2016

Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites

Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA

OncoTargets and Therapy 2016, 9:4549-4559

Published Date: 26 July 2016

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies

Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB

OncoTargets and Therapy 2016, 9:4517-4526

Published Date: 22 July 2016

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer

Zhao L, Zheng XY

OncoTargets and Therapy 2016, 9:4505-4516

Published Date: 22 July 2016

Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies

Jiang X, Zhang M, Bai XY, Li S, Wu H

OncoTargets and Therapy 2016, 9:4491-4503

Published Date: 22 July 2016

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ

OncoTargets and Therapy 2016, 9:4483-4489

Published Date: 21 July 2016

Clinical significance of TIPE expression in gastric carcinoma

Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z

OncoTargets and Therapy 2016, 9:4473-4481

Published Date: 25 July 2016

Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery

Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G

OncoTargets and Therapy 2016, 9:4465-4471

Published Date: 21 July 2016

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia

Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL

OncoTargets and Therapy 2016, 9:4453-4464

Published Date: 20 July 2016

Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK

OncoTargets and Therapy 2016, 9:4441-4451

Published Date: 21 July 2016

Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature

Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A

OncoTargets and Therapy 2016, 9:4435-4440

Published Date: 20 July 2016

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP

OncoTargets and Therapy 2016, 9:4425-4433

Published Date: 20 July 2016

Functions and mechanisms of long noncoding RNAs in lung cancer

Peng ZZ, Zhang CF, Duan CJ

OncoTargets and Therapy 2016, 9:4411-4424

Published Date: 20 July 2016

FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer

Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L

OncoTargets and Therapy 2016, 9:4397-4409

Published Date: 19 July 2016

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer

Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX

OncoTargets and Therapy 2016, 9:4377-4385

Published Date: 19 July 2016

Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies

Bai K, Cai Q, Jiang Y, Lv L

OncoTargets and Therapy 2016, 9:4369-4375

Published Date: 19 July 2016

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V

OncoTargets and Therapy 2016, 9:4351-4355

Published Date: 21 July 2016

Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction

Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y

OncoTargets and Therapy 2016, 9:4343-4349

Published Date: 18 July 2016

Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis

Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY

OncoTargets and Therapy 2016, 9:4337-4342

Published Date: 18 July 2016

Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance

Pyszniak M, Tabarkiewicz J, Łuszczki JJ

OncoTargets and Therapy 2016, 9:4323-4336

Published Date: 18 July 2016

Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature

Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J

OncoTargets and Therapy 2016, 9:4301-4305

Published Date: 15 July 2016

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma

Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF

OncoTargets and Therapy 2016, 9:4289-4293

Published Date: 14 July 2016

Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies

Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP

OncoTargets and Therapy 2016, 9:4277-4288

Published Date: 14 July 2016

Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma

Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:4257-4264

Published Date: 13 July 2016

Comparison of tumor markers using different detection devices [Retraction]

Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF

OncoTargets and Therapy 2016, 9:4255-4256

Published Date: 15 July 2016

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus

Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP

OncoTargets and Therapy 2016, 9:4239-4246

Published Date: 12 July 2016

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo

Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B

OncoTargets and Therapy 2016, 9:4215-4224

Published Date: 11 July 2016

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy

Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B

OncoTargets and Therapy 2016, 9:4207-4213

Published Date: 11 July 2016

Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer

Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD

OncoTargets and Therapy 2016, 9:4197-4205

Published Date: 11 July 2016

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation

Zhu Y, Li M, Kong L, Yu J

OncoTargets and Therapy 2016, 9:4187-4196

Published Date: 11 July 2016

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C

OncoTargets and Therapy 2016, 9:4173-4180

Published Date: 8 July 2016

Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis

Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y

OncoTargets and Therapy 2016, 9:4163-4171

Published Date: 7 July 2016

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer

Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W

OncoTargets and Therapy 2016, 9:4151-4162

Published Date: 7 July 2016

Fundamental effects of PD-1 antibody on the body: a brief report

Wang W, Liu B, Liu G, Guo W

OncoTargets and Therapy 2016, 9:4137-4141

Published Date: 7 July 2016

Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy

Chen ZS, Zhu SL, Qi LN, Li LQ

OncoTargets and Therapy 2016, 9:4129-4135

Published Date: 6 July 2016

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer

Liu H, Huang C, Wu L, Wen B

OncoTargets and Therapy 2016, 9:4121-4127

Published Date: 6 July 2016

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M

OncoTargets and Therapy 2016, 9:4113-4120

Published Date: 7 July 2016

Targeted therapy for localized non-small-cell lung cancer: a review

Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C

OncoTargets and Therapy 2016, 9:4099-4104

Published Date: 5 July 2016

The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM

OncoTargets and Therapy 2016, 9:4089-4098

Published Date: 5 July 2016

LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo

Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC

OncoTargets and Therapy 2016, 9:4075-4087

Published Date: 4 July 2016

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis

De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C

OncoTargets and Therapy 2016, 9:4043-4052

Published Date: 4 July 2016

Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

He W, Zhang Y, Xiong Y, Dai FJ, Fan QX

OncoTargets and Therapy 2016, 9:4037-4041

Published Date: 1 July 2016

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma

Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q

OncoTargets and Therapy 2016, 9:4023-4035

Published Date: 1 July 2016

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis

Wei B, Yang S, Zhang B, Feng Y

OncoTargets and Therapy 2016, 9:4015-4022

Published Date: 1 July 2016

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman

Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C

OncoTargets and Therapy 2016, 9:3993-3996

Published Date: 1 July 2016

Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump

Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3985-3992

Published Date: 30 June 2016

Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway

Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X

OncoTargets and Therapy 2016, 9:3963-3973

Published Date: 30 June 2016

Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression

Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y

OncoTargets and Therapy 2016, 9:3951-3962

Published Date: 4 July 2016

The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells

Xing YN, Zhang JY, Xu HM

OncoTargets and Therapy 2016, 9:3939-3949

Published Date: 29 June 2016

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma

Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W

OncoTargets and Therapy 2016, 9:3925-3937

Published Date: 30 June 2016

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review

Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L

OncoTargets and Therapy 2016, 9:3917-3923

Published Date: 29 June 2016

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma

Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J

OncoTargets and Therapy 2016, 9:3901-3906

Published Date: 29 June 2016

Association between pesticide exposure and risk of kidney cancer: a meta-analysis

Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP

OncoTargets and Therapy 2016, 9:3893-3900

Published Date: 28 June 2016

Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis

Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B

OncoTargets and Therapy 2016, 9:3883-3891

Published Date: 27 June 2016

Internal mammary sentinel lymph node biopsy: abandon or persist?

Qiu PF, Liu YB, Wang YS

OncoTargets and Therapy 2016, 9:3879-3882

Published Date: 27 June 2016

The clinical significance of γ-catenin in acute myeloid leukemia

Xu J, Wu W, Shen W, Liu P

OncoTargets and Therapy 2016, 9:3861-3871

Published Date: 27 June 2016

Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis

Wang HS, Nie XB, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD

OncoTargets and Therapy 2016, 9:3849-3860

Published Date: 27 June 2016

LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X

OncoTargets and Therapy 2016, 9:3829-3840

Published Date: 24 June 2016

Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix

Li C, Liu WH, Cheng YF

OncoTargets and Therapy 2016, 9:3791-3797

Published Date: 23 June 2016

Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort

Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH

OncoTargets and Therapy 2016, 9:3783-3789

Published Date: 23 June 2016

Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies

Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C

OncoTargets and Therapy 2016, 9:3727-3737

Published Date: 22 June 2016

Correlation of primary middle and distal esophageal cancers motion with surrounding tissues using four-dimensional computed tomography

Wang W, Li J, Zhang Y, Shao Q, Xu M, Guo B, Shang D

OncoTargets and Therapy 2016, 9:3705-3710

Published Date: 22 June 2016

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte PF, Favaretto A

OncoTargets and Therapy 2016, 9:3671-3681

Published Date: 21 June 2016

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B, Wang J

OncoTargets and Therapy 2016, 9:3661-3669

Published Date: 20 June 2016

Potential role of S-adenosylmethionine in osteosarcoma development

Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS

OncoTargets and Therapy 2016, 9:3653-3659

Published Date: 20 June 2016

MicroRNA-190 regulates FOXP2 genes in human gastric cancer

Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X, Xiao G

OncoTargets and Therapy 2016, 9:3643-3651

Published Date: 20 June 2016

The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma

Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY

OncoTargets and Therapy 2016, 9:3633-3642

Published Date: 20 June 2016

A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients

Huo Z, Yu S, Hong S, Cao X, Xiu L, Liao Z, Li Y, Xiao H

OncoTargets and Therapy 2016, 9:3621-3631

Published Date: 20 June 2016

Roles of microRNA-99 family in human glioma

Zhang MY, Guo Y, Wu J, Chen FH, Dai ZJ, Fan SS, Li PC, Song T

OncoTargets and Therapy 2016, 9:3613-3619

Published Date: 20 June 2016

XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment

Liu JM, Zhang J, Huang LW, Zhu XH, Chen W, Hu P

OncoTargets and Therapy 2016, 9:3603-3612

Published Date: 17 June 2016

High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis

Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ

OncoTargets and Therapy 2016, 9:3595-3602

Published Date: 16 June 2016

MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway

Zhang H, Cao H, Xu D, Zhu K

OncoTargets and Therapy 2016, 9:3579-3588

Published Date: 16 June 2016

1p/19q codeletion and RET rearrangements in small-cell lung cancer

Lu H, Xu H, Xie F, Qin J, Han N, Fan Y, Mao W

OncoTargets and Therapy 2016, 9:3571-3577

Published Date: 16 June 2016

Association between GSTP1 Ile105Val polymorphism and urinary system cancer risk: evidence from 51 studies

Zhang Y, Yuan Y, Chen Y, Wang Z, Li F, Zhao Q

OncoTargets and Therapy 2016, 9:3565-3569

Published Date: 15 June 2016

miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1

Zhang C, Chen X, Chen X, Wang X, Ji A, Jiang L, Sang F, Li F

OncoTargets and Therapy 2016, 9:3555-3563

Published Date: 15 June 2016

Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue

Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J

OncoTargets and Therapy 2016, 9:3545-3554

Published Date: 15 June 2016

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor

Xiao Y, Tian Q, He J, Huang M, Yang C, Gong L

OncoTargets and Therapy 2016, 9:3535-3544

Published Date: 15 June 2016

Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals

Li HX, Peng XX, Zong Q, Zhang K, Wang MX, Liu YZ, Han GL

OncoTargets and Therapy 2016, 9:3511-3523

Published Date: 14 June 2016

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy

Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W

OncoTargets and Therapy 2016, 9:3501-3509

Published Date: 13 June 2016

PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis

Han F, Hu R, Yang H, Liu J, Sui J, Xiang X, Wang F, Chu L, Song S

OncoTargets and Therapy 2016, 9:3485-3492

Published Date: 13 June 2016

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells

Liu Y, Sun B, Liu T, Zhao X, Wang X, Li Y, Meng J, Gu Q, Liu F, Dong X, Liu P, Sun R, Zhao N

OncoTargets and Therapy 2016, 9:3473-3484

Published Date: 13 June 2016

Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells

Ma H, Yao Y, Wang C, Zhang L, Cheng L, Wang Y, Wang T, Liang E, Jia H, Ye Q, Hou M, Feng F

OncoTargets and Therapy 2016, 9:3451-3463

Published Date: 13 June 2016

Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice

Li HY, Gu LL, Zhong YY, Chen YJ, Zhang L, Zhang AR, Sobol RW, Chen T, Li J

OncoTargets and Therapy 2016, 9:3433-3441

Published Date: 8 June 2016

GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2

Huang F, Yin J, Li K, Li Y, Qi H, Fang L, Yuan C, Liu W, Wang M, Li X

OncoTargets and Therapy 2016, 9:3415-3422

Published Date: 7 June 2016

The prognostic roles of ALDH1 isoenzymes in gastric cancer

Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y

OncoTargets and Therapy 2016, 9:3405-3414

Published Date: 7 June 2016

CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population

Su L, Gao SJ, Liu XL, Tan YH, Wang L, Li W

OncoTargets and Therapy 2016, 9:3399-3403

Published Date: 3 June 2016

A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors

Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G

OncoTargets and Therapy 2016, 9:3387-3398

Published Date: 3 June 2016

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors

Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:3369-3380

Published Date: 2 June 2016

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z

OncoTargets and Therapy 2016, 9:3359-3368

Published Date: 2 June 2016

Significant association between long non-coding RNA HOTAIR polymorphisms and cancer susceptibility: a meta-analysis

Zhang J, Liu X, You LH, Zhou RZ

OncoTargets and Therapy 2016, 9:3335-3343

Published Date: 1 June 2016

Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report

Zhang Y, Li HS, Li ZJ, Liu M, Yang L, Fan LY, Huang CS, Li BS

OncoTargets and Therapy 2016, 9:3327-3333

Published Date: 2 June 2016

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer

Choi YJ, Chang WJ, Shin SW, Park KH, Kim ST, Kim YH

OncoTargets and Therapy 2016, 9:3307-3312

Published Date: 1 June 2016

Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

Qiao XJ, Zhai XR, Wang JH, Zhao XT, Yang XJ, Lv JL, Ma L, Zhang LN, Wang Y, Zhang SC, Yue WT

OncoTargets and Therapy 2016, 9:3299-3305

Published Date: 1 June 2016

Clinical significance of B7-H6 protein expression in astrocytoma

Guo JG, Guo CC, He ZQ, Liu ZG, Wang Y, Mou YG

OncoTargets and Therapy 2016, 9:3291-3297

Published Date: 31 May 2016

MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET

Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z, Sun J

OncoTargets and Therapy 2016, 9:3281-3289

Published Date: 31 May 2016

Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma

Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A

OncoTargets and Therapy 2016, 9:3269-3280

Published Date: 31 May 2016

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis

Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J

OncoTargets and Therapy 2016, 9:3233-3247

Published Date: 30 May 2016

The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy

Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X, Cai X

OncoTargets and Therapy 2016, 9:3213-3221

Published Date: 30 May 2016

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis

Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN

OncoTargets and Therapy 2016, 9:3205-3212

Published Date: 27 May 2016

Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review

Zhao F, Li MH, Kong L, Zhang GL, Yu JM

OncoTargets and Therapy 2016, 9:3197-3204

Published Date: 27 May 2016

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer

Ang YLE, Lim JS, Soo RA

OncoTargets and Therapy 2016, 9:3187-3195

Published Date: 30 May 2016

Clinical features and treatment of squamous cell carcinoma of the breast

Zhang XM, Zhang BZ, Zang FL, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3181-3185

Published Date: 27 May 2016

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy

Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S

OncoTargets and Therapy 2016, 9:3171-3179

Published Date: 27 May 2016

Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study

Mumm JN, Kölbl AC, Jeschke U, Andergassen U

OncoTargets and Therapy 2016, 9:3163-3169

Published Date: 26 May 2016

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency

Bian X, Wu P, Sha H, Qian H, Wang Q, Cheng L, Yang Y, Yang M, Liu B

OncoTargets and Therapy 2016, 9:3153-3162

Published Date: 27 May 2016

Effect of YAP1 silencing on esophageal cancer

Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S

OncoTargets and Therapy 2016, 9:3137-3146

Published Date: 26 May 2016

Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum]

Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y

OncoTargets and Therapy 2016, 9:3135-3136

Published Date: 27 May 2016

Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis

Dong YW, Shi YQ, He LW, Su PZ

OncoTargets and Therapy 2016, 9:3127-3134

Published Date: 25 May 2016

MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1

Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W

OncoTargets and Therapy 2016, 9:3101-3111

Published Date: 24 May 2016

Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy

Joo JH, Kim YJ, Kim YS, Cho YP, Lee HY, Jeong CY, Kwak J, Cho BC

OncoTargets and Therapy 2016, 9:3095-3100

Published Date: 24 May 2016

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL

OncoTargets and Therapy 2016, 9:3085-3094

Published Date: 26 May 2016

Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer

Lu Y, Zhou XH, Xu L, Rong CH, Shen C, Bian W

OncoTargets and Therapy 2016, 9:3077-3084

Published Date: 24 May 2016

Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells

Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ

OncoTargets and Therapy 2016, 9:3067-3076

Published Date: 27 May 2016

URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient

Yu G, Meng QX, Zhang T, Zeng C, He BF, Zhang SS

OncoTargets and Therapy 2016, 9:3059-3065

Published Date: 23 May 2016

Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis

Liu XD, Luo ZY, Peng HX, Jiang H, Xu L

OncoTargets and Therapy 2016, 9:3039-3047

Published Date: 23 May 2016

Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports

Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK

OncoTargets and Therapy 2016, 9:3017-3023

Published Date: 20 May 2016

Targeting gastrointestinal stromal tumors: the role of regorafenib

Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM

OncoTargets and Therapy 2016, 9:3009-3016

Published Date: 20 May 2016

Onivyde for the therapy of multiple solid tumors

Zhang H

OncoTargets and Therapy 2016, 9:3001-3007

Published Date: 20 May 2016

Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis

Xue Y, Jiang Y, Jin S, Li Y

OncoTargets and Therapy 2016, 9:2987-2992

Published Date: 19 May 2016

Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer

Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L

OncoTargets and Therapy 2016, 9:2975-2986

Published Date: 19 May 2016

Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses

Wang HY, Hsu MK, Wang KH, Tseng CP, Chen FC, Hsu JTA

OncoTargets and Therapy 2016, 9:2961-2973

Published Date: 19 May 2016

Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature

Wang XL, Yan HJ, Luo YJ, Fan TY

OncoTargets and Therapy 2016, 9:2955-2959

Published Date: 18 May 2016

Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors

Wu X, Zhang H, Salmani JMM, Fu R, Chen B

OncoTargets and Therapy 2016, 9:2935-2943

Published Date: 17 May 2016

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2016, 9:2911-2917

Published Date: 17 May 2016

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway

Zhang JY, Jiang H, Xie L, Hu J, Li L, Yang M, Cheng L, Liu BR, Qian XP

OncoTargets and Therapy 2016, 9:2885-2895

Published Date: 24 May 2016

Recent advancements in erythrocytes, platelets, and albumin as delivery systems

Xu PP, Wang RJ, Wang XH, Ouyang J

OncoTargets and Therapy 2016, 9:2873-2884

Published Date: 17 May 2016

miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma

Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H

OncoTargets and Therapy 2016, 9:2865-2871

Published Date: 19 May 2016

Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway

Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, Wu H

OncoTargets and Therapy 2016, 9:2845-2853

Published Date: 12 May 2016

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

Shakespeare TP, Wilcox SW, Aherne NJ

OncoTargets and Therapy 2016, 9:2819-2824

Published Date: 11 May 2016

Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage

Zhao W, Zhang C, Bi C, Ye C, Song D, Liu X, Shao R

OncoTargets and Therapy 2016, 9:2805-2817

Published Date: 11 May 2016

Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells

Fan SL, Li X, Li LM, Wang LG, Du ZZ, Yang Y, Zhao JS, Li Y

OncoTargets and Therapy 2016, 9:2795-2803

Published Date: 10 May 2016

Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors

Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B

OncoTargets and Therapy 2016, 9:2769-2781

Published Date: 10 May 2016

Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report

Sun LC, Qi YL, Sun XD, Yu JM, Meng X

OncoTargets and Therapy 2016, 9:2743-2748

Published Date: 9 May 2016

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D

OncoTargets and Therapy 2016, 9:2735-2742

Published Date: 6 May 2016

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma

Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G

OncoTargets and Therapy 2016, 9:2725-2733

Published Date: 6 May 2016

Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile

Zhang M, Li H, Zou D, Gao J

OncoTargets and Therapy 2016, 9:2717-2723

Published Date: 5 May 2016

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy

Wang J, Tian Y, Tang Y, Wang X, Li N, Ren H, Fang H, Feng Y, Wang S, Song Y, Liu Y, Wang W, Li Y, Jin J

OncoTargets and Therapy 2016, 9:2701-2707

Published Date: 5 May 2016

HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis

Liu FT, Ou YX, Zhang GP, Qiu C, Luo HL, Zhu PQ

OncoTargets and Therapy 2016, 9:2693-2699

Published Date: 6 May 2016

Shorter telomere length of T-cells in peripheral blood of patients with lung cancer

Qian Y, Ding T, Wei L, Cao S, Yang L

OncoTargets and Therapy 2016, 9:2675-2682

Published Date: 4 May 2016

Emerging treatment options for myelofibrosis: focus on pacritinib

Chow V, Weissman A, O’Connell CL, Mehrvar A, Akhtari M

OncoTargets and Therapy 2016, 9:2655-2665

Published Date: 4 May 2016

Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis

Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS

OncoTargets and Therapy 2016, 9:2649-2654

Published Date: 4 May 2016

miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7

Hong LQ, Pan F, Jiang HF, Zhang LH, Liu YH, Cai CS, Hua CZ, Luo X, Sun JH, Chen ZJ

OncoTargets and Therapy 2016, 9:2639-2648

Published Date: 4 May 2016

Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis

Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y

OncoTargets and Therapy 2016, 9:2615-2624

Published Date: 4 May 2016

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CHA

OncoTargets and Therapy 2016, 9:2601-2613

Published Date: 3 May 2016